☰

Jean Addington - Publications

Affiliations: 
University of Calgary, Calgary, Alberta, Canada 
Area:
Clinical Psychology
Tree Info Grants Similar researchers PubMed Report error

328/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Nogovitsyn N, Ballester P, Lasby M, Dunlop K, Ceniti AK, Squires S, Rowe J, Ho K, Suh J, Hassel S, Souza R, Casseb RF, Harris JK, Zamyadi M, Arnott SR, ... ... Addington J, et al. An empirical analysis of structural neuroimaging profiles in a staging model of depression. Journal of Affective Disorders. PMID 38290583 DOI: 10.1016/j.jad.2024.01.246  0.796
2023 Worthington MA, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Cannon TD. Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator. Psychological Medicine. 1-9. PMID 37642172 DOI: 10.1017/S0033291723002301  0.3
2023 Jalali S, Liu L, Wang J, Kennedy SH, MacQueen G, Lebel C, Goldstein BL, Bray S, Addington J. Factors Associated with Transition to Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231195959. PMID 37606525 DOI: 10.1177/07067437231195959  0.638
2022 Sefik E, Boamah M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Cannon TD, Walker EF. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 36394426 DOI: 10.1093/schbul/sbac169  0.303
2022 Barbato M, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, ... Addington J, et al. Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study. Social Psychiatry and Psychiatric Epidemiology. PMID 36348056 DOI: 10.1007/s00127-022-02383-y  0.312
2022 Metzak PD, Shakeel MK, Long X, Lasby M, Souza R, Bray S, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Addington J, Lebel C. Brain connectomes in youth at risk for serious mental illness: an exploratory analysis. Bmc Psychiatry. 22: 611. PMID 36109720 DOI: 10.1186/s12888-022-04118-4  0.606
2022 Santesteban-Echarri O, Sandel D, Liu L, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, ... ... Addington J, et al. Family history of psychosis in youth at clinical high risk: A replication study. Psychiatry Research. 311: 114480. PMID 35245743 DOI: 10.1016/j.psychres.2022.114480  0.328
2022 Nogovitsyn N, Metzak PD, Casseb RF, Souza R, Harris JK, Prati LM, Zamyadi M, Bray SL, Lebel C, Hassel S, Strother S, Goldstein BI, Wang J, Kennedy SH, MacQueen GM, ... Addington J, et al. Cerebello-limbic functional connectivity patterns in youth at clinical high risk for psychosis. Schizophrenia Research. 240: 220-227. PMID 35074702 DOI: 10.1016/j.schres.2021.12.041  0.803
2021 Shakeel MK, Hassel S, Davis AD, Metzak PD, MacQueen GM, Arnott SR, Bray S, Frey BN, Goldstein BI, Hall GB, Harris J, Lam RW, MacIntosh BJ, Milev R, Mueller DJ, ... ... Addington J, et al. White matter microstructure in youth at risk for serious mental illness: A comparative analysis. Psychiatry Research. Neuroimaging. 312: 111289. PMID 33910139 DOI: 10.1016/j.pscychresns.2021.111289  0.693
2021 Farris MS, Braun A, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Addington J. Longitudinal Trends in Medication Treatment for Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720988450. PMID 33464130 DOI: 10.1177/0706743720988450  0.602
2020 Metzak PD, Addington J, Hassel S, Goldstein BI, MacIntosh BJ, Lebel C, Wang JL, Kennedy SH, MacQueen GM, Bray S. Functional imaging in youth at risk for transdiagnostic serious mental illness: Initial results from the PROCAN study. Early Intervention in Psychiatry. PMID 33295151 DOI: 10.1111/eip.13078  0.598
2020 Addington J, Liu L, Farris MS, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, MacQueen G. Clinical staging for youth at-risk for serious mental illness: A longitudinal perspective. Early Intervention in Psychiatry. PMID 33037783 DOI: 10.1111/eip.13062  0.623
2020 Corbett S, Metzak P, MacQueen G, Farris M, Addington J. Aerobic exercise and hippocampal change in youth at risk of serious mental illness. Psychiatry Research. Neuroimaging. 305: 111199. PMID 33035755 DOI: 10.1016/j.pscychresns.2020.111199  0.479
2020 Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Frontiers in Psychiatry. 11: 833. PMID 33005152 DOI: 10.3389/Fpsyt.2020.00833  0.418
2020 Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, ... ... Addington J, et al. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophrenia Research. PMID 32943313 DOI: 10.1016/J.Schres.2020.08.014  0.405
2020 Nogovitsyn N, Addington J, Souza R, Placsko TJ, Stowkowy J, Wang J, Goldstein BI, Bray S, Lebel C, Taylor VH, Kennedy SH, MacQueen G. Childhood trauma and amygdala nuclei volumes in youth at risk for mental illness. Psychological Medicine. 1-8. PMID 32940197 DOI: 10.1017/S0033291720003177  0.791
2020 LoPilato AM, Zhang Y, Pike M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms. Early Intervention in Psychiatry. PMID 32770658 DOI: 10.1111/Eip.13017  0.348
2020 Metzak PD, Devoe DJ, Iwaschuk A, Braun A, Addington J. Brain changes associated with negative symptoms in clinical high risk for psychosis: A systematic review. Neuroscience and Biobehavioral Reviews. 118: 367-383. PMID 32768487 DOI: 10.1016/J.Neubiorev.2020.07.041  0.381
2020 Shakeel MK, MacQueen G, Addington J, Metzak PD, Georgopoulos G, Bray S, Goldstein BI, MacIntosh BJ, Wang J, Kennedy SH, Lebel C. White Matter Connectivity in Youth at Risk for Serious Mental Illness: A Longitudinal Analysis. Psychiatry Research. Neuroimaging. 302: 111106. PMID 32505905 DOI: 10.1016/J.Pscychresns.2020.111106  0.639
2020 Farris MS, Shakeel MK, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Substance use in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32500614 DOI: 10.1111/Eip.12995  0.655
2020 Kozloff N, Foussias G, Durbin J, Sockalingam S, Addington J, Addington D, Ampofo A, Anderson KK, Barwick M, Bromley S, Cunningham JEA, Dahrouge S, Duda L, Ford C, Gallagher S, et al. Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults. Bmj Open. 10: e034280. PMID 32499262 DOI: 10.1136/Bmjopen-2019-034280  0.302
2020 Corbett S, Farris MS, MacQueen G, Addington J. Pilot aerobic exercise intervention for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 32452641 DOI: 10.1111/Eip.12977  0.508
2020 Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, et al. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophrenia Research. PMID 32402605 DOI: 10.1016/J.Schres.2020.04.020  0.345
2020 Devoe DJ, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study. Schizophrenia Research. PMID 32362460 DOI: 10.1016/J.Schres.2020.04.004  0.419
2020 Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, et al. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophrenia Research. PMID 32317224 DOI: 10.1016/J.Schres.2020.04.010  0.333
2020 Santesteban-Echarri O, Tang J, Shakeel MK, Fernandes J, Addington J. A mobile-based app to monitor social functioning among youth at-risk for psychosis: Single-arm feasibility and acceptability study. General Hospital Psychiatry. PMID 32317101 DOI: 10.1016/J.Genhosppsych.2020.04.003  0.333
2020 Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Kenney JG, Light G, Niznikiewicz M, Addington J, Bearden CE, Owens EM, Cadenhead KS, Cannon TD, et al. Stability of mismatch negativity event-related potentials in a multisite study. International Journal of Methods in Psychiatric Research. e1819. PMID 32232944 DOI: 10.1002/Mpr.1819  0.307
2020 Cullen AE, Addington J, Bearden CE, Stone WS, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Psychoneuroendocrinology. 115: 104649. PMID 32197198 DOI: 10.1016/J.Psyneuen.2020.104649  0.339
2020 Nogovitsyn N, Souza R, Muller M, Srajer A, Metzak PD, Hassel S, Ismail Z, Protzner A, Bray SL, Lebel C, MacIntosh BJ, Goldstein BI, Wang J, Kennedy SH, Addington J, et al. Aberrant limbic brain structures in young individuals at risk for mental illness. Psychiatry and Clinical Neurosciences. PMID 32003517 DOI: 10.1111/Pcn.12985  0.802
2020 Velikonja T, Velthorst E, Zinberg J, Cannon TD, Cornblatt BA, Perkins DO, Cadenhead KS, Tsuang MT, Addington J, Woods SW, McGlashan T, Mathalon DH, Stone W, Keshavan M, Seidman L, et al. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis. Development and Psychopathology. 1-12. PMID 31959269 DOI: 10.1017/S095457941900155X  0.377
2020 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Personality and risk for serious mental illness. Early Intervention in Psychiatry. PMID 31910491 DOI: 10.1111/Eip.12921  0.662
2020 Stowkowy J, Goldstein BI, MacQueen G, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Trauma in Youth At-Risk for Serious Mental Illness. The Journal of Nervous and Mental Disease. 208: 70-76. PMID 31834192 DOI: 10.1097/Nmd.0000000000001069  0.656
2020 Santesteban-Echarri O, Tang J, Fernandes J, Addington J. S106. Monitoring Social Functioning Through A Mobile-Based Application For Youth At-Risk Of Psychosis: 2-Month Feasibility Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.172  0.332
2020 Santesteban-Echarri O, Kim GH, Haffey P, Tang J, Addington J. M100. Looseleaf: Developing A Mobile-Based Application To Monitor Daily Cannabis Usage In Youth At Clinical High-Risk Of Psychosis: App Development And Usability Testing Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.412  0.331
2020 Worthington M, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Cannon T. T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S274-S275. DOI: 10.1093/Schbul/Sbaa029.676  0.366
2020 Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Johannesen J, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cornblatt B, McGlashan T, Perkins D, Seidman L, et al. O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY Schizophrenia Bulletin. 46: S24-S25. DOI: 10.1093/Schbul/Sbaa028.056  0.327
2020 Di Biase M, Cetin Karayumak S, Zalesky A, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Higger M, Anticevic A, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, et al. O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT Schizophrenia Bulletin. 46: S13-S13. DOI: 10.1093/Schbul/Sbaa028.029  0.35
2019 Yoviene Sykes LA, Ferrara M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woodberry KA, Powers AR, et al. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis. Schizophrenia Research. PMID 31864837 DOI: 10.1016/J.Schres.2019.12.002  0.382
2019 Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Duration of the psychosis prodrome. Schizophrenia Research. PMID 31806523 DOI: 10.1016/J.Schres.2019.10.051  0.332
2019 Farris MS, Shakeel MK, Addington J. Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review. Social Psychiatry and Psychiatric Epidemiology. PMID 31796983 DOI: 10.1007/s00127-019-01810-x  0.318
2019 Stowkowy J, Brummitt K, Bonneville D, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, MacQueen G, Addington J. Sleep disturbances in youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 31724327 DOI: 10.1111/Eip.12898  0.613
2019 Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, et al. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. The American Journal of Psychiatry. appiajp201918060721. PMID 31711302 DOI: 10.1176/Appi.Ajp.2019.18060721  0.371
2019 Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, et al. Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31610545 DOI: 10.1038/S41386-019-0542-1  0.771
2019 Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. The American Journal of Psychiatry. appiajp201918111290. PMID 31509005 DOI: 10.1176/Appi.Ajp.2019.18111290  0.407
2019 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Social and role functioning in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 31502422 DOI: 10.1111/Eip.12872  0.665
2019 Farris MS, Devoe DJ, Addington J. Attrition rates in trials for adolescents and young adults at clinical high-risk for psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 31422583 DOI: 10.1111/Eip.12864  0.355
2019 Addington J, Devoe DJ, Santesteban-Echarri O. Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis. Current Treatment Options in Psychiatry. 6: 1-16. PMID 31403023 DOI: 10.1007/S40501-019-0164-6  0.388
2019 Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. Jama Psychiatry. PMID 31389974 DOI: 10.1001/Jamapsychiatry.2019.2135  0.406
2019 Goines KB, LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Research. 112492. PMID 31387769 DOI: 10.1016/J.Psychres.2019.112492  0.314
2019 Addington J, Shakeel MK, Braun A, Bonneville D, Stowkowy J. Metacognition in youth at-risk for psychosis. Schizophrenia Research. PMID 31296413 DOI: 10.1016/J.Schres.2019.07.005  0.383
2019 Malda A, Boonstra N, Barf H, de Jong S, Aleman A, Addington J, Pruessner M, Nieman D, de Haan L, Morrison A, Riecher-Rössler A, Studerus E, Ruhrmann S, Schultze-Lutter F, An SK, et al. Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis. Frontiers in Psychiatry. 10: 345. PMID 31178767 DOI: 10.3389/Fpsyt.2019.00345  0.39
2019 Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, et al. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage. Clinical. 23: 101862. PMID 31150956 DOI: 10.1016/J.Nicl.2019.101862  0.415
2019 Nogovitsyn N, Souza R, Muller M, Srajer A, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Bray SL, Lebel C, Addington JM, et al. Testing a deep convolutional neural network for automated hippocampus segmentation in a longitudinal sample of healthy participants. Neuroimage. PMID 31075395 DOI: 10.1016/J.Neuroimage.2019.05.017  0.758
2019 Addington J, Farris M, Stowkowy J, Santesteban-Echarri O, Metzak P, Kalathil MS. Predictors of Transition to Psychosis in Individuals at Clinical High Risk. Current Psychiatry Reports. 21: 39. PMID 31037392 DOI: 10.1007/S11920-019-1027-Y  0.406
2019 Shakeel MK, Lu L, Woods SW, Perkins DO, Addington J. Neurocognitive predictors of metacognition in individuals at clinical high risk for psychosis. Behavioural and Cognitive Psychotherapy. 1-5. PMID 30982487 DOI: 10.1017/S1352465819000328  0.419
2019 Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, et al. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk For Psychosis Services. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797038 DOI: 10.1016/J.Jaac.2018.09.446  0.367
2019 LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophrenia Research. PMID 30745068 DOI: 10.1016/J.Schres.2019.01.048  0.403
2019 Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophrenia Research. PMID 30745066 DOI: 10.1016/J.Schres.2019.01.026  0.324
2019 Addington J, Liu L, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Stowkowy J, MacQueen G. Clinical staging for youth at-risk for serious mental illness. Early Intervention in Psychiatry. PMID 30672153 DOI: 10.1111/Eip.12786  0.648
2019 Devoe D, Liu L, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Bearden C, Mathalon D, Addington J. S21. THE IMPACT OF PERSISTENT NEGATIVE SYMPTOMS ON FUNCTIONING AND DEFEATIST BELIEFS IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 45: S313-S313. DOI: 10.1093/Schbul/Sbz020.566  0.408
2019 Devoe D, Addington J. T29. TREATMENT AND GLOBAL FUNCTIONING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS Schizophrenia Bulletin. 45: S214-S214. DOI: 10.1093/Schbul/Sbz019.309  0.342
2019 Martin AS, Johannesen J, Roach B, Hamilton H, Bachman P, Belger A, Carrión R, Duncan E, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, et al. S190. Does Cannabis Use Interact With Neurophysiological Vulnerability in the Early Expression of Psychosis and Conversion Status in Clinical High-Risk (CHR) Individuals? Biological Psychiatry. 85: S370-S371. DOI: 10.1016/J.Biopsych.2019.03.941  0.374
2019 Nogovitsyn N, Srajer A, Muller M, Metzak P, Hassel S, Souza R, Bray S, Lebel C, Goldstein B, Kennedy S, Ismail Z, Protzner A, Addington J, MacQueen G. F130. Subfield-Specific Hippocampal Volumes in Youth at Risk for Mental Illness Biological Psychiatry. 85: S263-S264. DOI: 10.1016/J.Biopsych.2019.03.667  0.787
2019 Desjardins C, Nogovitsyn N, Souza R, Hassel S, Arnott S, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Bray S, Lebel C, Addington J, Milev R, Harkness K, et al. F113. Hippocampal Subfield-Specific Sex Differences in Patients With Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.650  0.761
2019 Ramyead A, Roach B, Hamilton H, Addington J, Bachman P, Bearden C, Belger A, Cadenhead K, Cannon T, Carrion R, Cornblatt B, Duncan E, Johannesen J, Light G, McGlashan T, et al. O33. EEG Alpha Event-Related Desynchronization Deficits Predict Conversion to Psychosis in Individuals With the Psychosis Risk Syndrome Biological Psychiatry. 85: S119. DOI: 10.1016/J.Biopsych.2019.03.298  0.304
2018 Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain, Behavior, and Immunity. PMID 30496778 DOI: 10.1016/J.Bbi.2018.11.315  0.34
2018 Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. Tobacco use and psychosis risk in persons at clinical high risk. Early Intervention in Psychiatry. PMID 30362261 DOI: 10.1111/Eip.12751  0.38
2018 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Neurocognitive deficits in a transdiagnostic clinical staging model. Psychiatry Research. PMID 30360915 DOI: 10.1016/J.Psychres.2018.10.030  0.663
2018 Carrión RE, Auther AM, McLaughlin D, Olsen R, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 30351423 DOI: 10.1093/Schbul/Sby126  0.386
2018 Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J, et al. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophrenia Research. PMID 30249470 DOI: 10.1016/J.Schres.2018.09.022  0.389
2018 Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, et al. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nature Communications. 9: 3836. PMID 30242220 DOI: 10.1038/S41467-018-06350-7  0.375
2018 Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, et al. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophrenia Bulletin. PMID 30215784 DOI: 10.1093/Schbul/Sby122  0.353
2018 Santesteban-Echarri O, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Family functioning in youth at-risk for serious mental illness. Comprehensive Psychiatry. 87: 17-24. PMID 30193153 DOI: 10.1016/J.Comppsych.2018.08.010  0.649
2018 Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophrenia Research. PMID 30181061 DOI: 10.1016/J.Schres.2018.08.032  0.336
2018 Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychological Medicine. 1-8. PMID 30176955 DOI: 10.1017/S0033291718002258  0.442
2018 Santesteban-Echarri O, Piskulic D, Nyman RK, Addington J. Telehealth interventions for schizophrenia-spectrum disorders and clinical high-risk for psychosis individuals: A scoping review. Journal of Telemedicine and Telecare. 1357633X18794100. PMID 30134781 DOI: 10.1177/1357633X18794100  0.398
2018 Velthorst E, Meyer EC, Giuliano AJ, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Seidman LJ. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophrenia Research. PMID 30078717 DOI: 10.1016/J.Schres.2018.07.038  0.377
2018 Farris MS, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. Treatment History of Youth At-Risk for Serious Mental Illness. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743718792195. PMID 30071747 DOI: 10.1177/0706743718792195  0.646
2018 Addington J, Goldstein BI, Wang JL, Kennedy SH, Bray S, Lebel C, Hassel S, Marshall C, MacQueen G. Youth at-risk for serious mental illness: methods of the PROCAN study. Bmc Psychiatry. 18: 219. PMID 29976184 DOI: 10.1186/S12888-018-1801-0  0.653
2018 Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. Jama Psychiatry. PMID 29971330 DOI: 10.1001/Jamapsychiatry.2018.1543  0.387
2018 Hampton JN, Trotman HD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, Walker EF. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress and Health : Journal of the International Society For the Investigation of Stress. PMID 29956456 DOI: 10.1002/Smi.2819  0.311
2018 Devoe DJ, Farris MS, Townes P, Addington J. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 29938910 DOI: 10.1111/Eip.12689  0.331
2018 Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, ... ... Addington J, et al. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. Jama Psychiatry. PMID 29800949 DOI: 10.1001/Jamapsychiatry.2018.0623  0.323
2018 Davidson CA, Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW, Johannesen JK. Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study. Schizophrenia Research. PMID 29751984 DOI: 10.1016/J.Schres.2018.05.001  0.356
2018 Devoe DJ, Farris MS, Townes P, Addington J. Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis. Early Intervention in Psychiatry. PMID 29749710 DOI: 10.1111/Eip.12677  0.373
2018 Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Woods SW. Erratum to: Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis Schizophrenia Bulletin. 44. PMID 29718467 DOI: 10.1093/Schbul/Sbx097  0.354
2018 Brodey BB, Girgis RR, Favorov OV, Addington J, Perkins DO, Bearden CE, Woods SW, Walker EF, Cornblatt BA, Brucato G, Walsh B, Elkin KA, Brodey IS. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning. Schizophrenia Research. PMID 29358019 DOI: 10.1016/J.Schres.2017.11.030  0.362
2018 Chung Y, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, McEwen S, van Erp T, Cannon T. S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK Schizophrenia Bulletin. 44: S396-S397. DOI: 10.1093/Schbul/Sby018.971  0.354
2018 Romanowska S, MacQueen G, Goldstein BI, Wang J, Kennedy SH, Bray S, Lebel C, Addington J. S80. NEUROCOGNITIVE FUNCTIONING IN YOUTH AT RISK OF SERIOUS MENTAL ILLNESS Schizophrenia Bulletin. 44: S355-S356. DOI: 10.1093/Schbul/Sby018.867  0.647
2018 Allswede D, Cannon T, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, Thomas M, Perkins D, Seidman L, Tsuang M, Walker E, Woods S. S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING Schizophrenia Bulletin. 44: S422-S422. DOI: 10.1093/Schbul/Sby018.1031  0.327
2018 Foss-Feig J, Velthorst E, Guillory S, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, et al. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER Schizophrenia Bulletin. 44: S266-S266. DOI: 10.1093/Schbul/Sby017.649  0.335
2018 Cullen A, Cadenhead KS, Addington J, Bearden CE, Cannon T, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman L, Stone WS, Tsuang M, Woods SW, Walker EF. O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT Schizophrenia Bulletin. 44: S102-S102. DOI: 10.1093/Schbul/Sby015.252  0.349
2018 Woodberry K, Stone WS, Shapiro DI, Chokran CM, Addington J, Bearden C, Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW, et al. O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS Schizophrenia Bulletin. 44: S78-S78. DOI: 10.1093/Schbul/Sby015.198  0.342
2018 Velthorst E, Bearden C, Meyer E, Giuliano A, Addington J, Cadenhead K, Cannon T, Cornblatt B, Mcglashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. 24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1 Schizophrenia Bulletin. 44: S39-S40. DOI: 10.1093/Schbul/Sby014.097  0.322
2018 Goldsmith D, Miller A, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Tsuang M, Woods S, Walker E. F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis Biological Psychiatry. 83: S330-S331. DOI: 10.1016/J.Biopsych.2018.02.850  0.364
2017 Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophrenia Research. PMID 29279247 DOI: 10.1016/J.Schres.2017.12.001  0.373
2017 Brodey BB, Addington J, First MB, Perkins DO, Woods SW, Walker EF, Walsh B, Nieri JM, Nunn MB, Putz J, Brodey IS. The Early Psychosis Screener (EPS): Item development and qualitative validation. Schizophrenia Research. PMID 29254878 DOI: 10.1016/J.Schres.2017.11.027  0.326
2017 Piskulic D, Romanowska S, Addington J. Pilot study of cognitive remediation and motivational interviewing in youth at risk of serious mental illness. Early Intervention in Psychiatry. PMID 29164824 DOI: 10.1111/Eip.12520  0.394
2017 Devoe DJ, Peterson A, Addington J. Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis. Schizophrenia Bulletin. PMID 29069511 DOI: 10.1093/Schbul/Sbx139  0.379
2017 Healey KM, Penn DL, Perkins D, Woods SW, Keefe RSE, Addington J. Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. Schizophrenia Bulletin. PMID 29036587 DOI: 10.1093/Schbul/Sbx080  0.389
2017 Woods SW, Powers AR, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophrenia Bulletin. PMID 29036402 DOI: 10.1093/Schbul/Sbx138  0.381
2017 Fulford D, Piskulic D, Addington J, Kane JM, Schooler NR, Mueser KT. Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia. Schizophrenia Bulletin. PMID 28981811 DOI: 10.1093/Schbul/Sbx096  0.375
2017 Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Research. PMID 28886901 DOI: 10.1016/J.Psychres.2017.08.045  0.382
2017 Tarbox-Berry SI, Perkins DO, Woods SW, Addington J. Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth. Psychological Medicine. 1-15. PMID 28874223 DOI: 10.1017/S0033291717002343  0.389
2017 Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Intervention in Psychiatry. PMID 28792113 DOI: 10.1111/Eip.12471  0.411
2017 Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, ... Addington J, et al. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Intervention in Psychiatry. PMID 28771938 DOI: 10.1111/Eip.12473  0.384
2017 Addington J, Addington D, Abidi S, Raedler T, Remington G. CPA Treatment Guidelines for Individuals at Clinical High Risk of Psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743717719895. PMID 28730848 DOI: 10.1177/0706743717719895  0.383
2017 Nagendra A, Schooler NR, Kane JM, Robinson DG, Mueser KT, Estroff SE, Addington J, Marcy P, Penn DL. Demographic, psychosocial, clinical, and neurocognitive baseline characteristics of Black Americans in the RAISE-ETP study. Schizophrenia Research. PMID 28709773 DOI: 10.1016/J.Schres.2017.06.038  0.314
2017 Brunette MF, Mueser KT, Babbin S, Meyer-Kalos P, Rosenheck R, Correll CU, Cather C, Robinson DG, Schooler NR, Penn DL, Addington J, Estroff SE, Gottlieb J, Glynn SM, Marcy P, et al. Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophrenia Research. PMID 28697856 DOI: 10.1016/J.Schres.2017.06.039  0.381
2017 Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophrenia Research. PMID 28578922 DOI: 10.1016/J.Schres.2017.05.032  0.339
2017 Browne J, Penn DL, Bauer DJ, Meyer-Kalos P, Mueser KT, Robinson DG, Addington J, Schooler NR, Glynn SM, Gingerich S, Marcy P, Kane JM. Perceived Autonomy Support in the NIMH RAISE Early Treatment Program. Psychiatric Services (Washington, D.C.). appips201600480. PMID 28566027 DOI: 10.1176/Appi.Ps.201600480  0.34
2017 Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Development and Psychopathology. 1-9. PMID 28420458 DOI: 10.1017/S0954579417000451  0.338
2017 Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophrenia Research. PMID 28372906 DOI: 10.1016/J.Schres.2017.03.043  0.411
2017 Chung Y, Haut KM, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, et al. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophrenia Research. PMID 28245961 DOI: 10.1016/J.Schres.2017.02.014  0.351
2017 Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, et al. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28186095 DOI: 10.1038/Npp.2017.34  0.307
2017 Devoe D, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Bearden C, Mathalon D, Addington J. SU127. Negative Symptoms in Youth at Clinical High Risk of Psychosis Schizophrenia Bulletin. 43: S207-S207. DOI: 10.1093/Schbul/Sbx024.123  0.407
2017 Carrion R, McLaughlin D, Auther A, Addington J, Bearden C, Cadenhead K, Cannon T, Tsuang M, Walker E, Woods SW, Cornblatt B. M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S253-S253. DOI: 10.1093/Schbul/Sbx022.112  0.348
2017 Mirzakhanian H, Sanchez S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cadenhead K. 209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology Schizophrenia Bulletin. 43: S106-S107. DOI: 10.1093/Schbul/Sbx021.287  0.413
2017 Davidson C, Piskulic D, Addington J, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Bearden C, Mathalon D, Woods S, Johannesen J. 192. Different Age-Related Trajectories of Social Cognition in Youths at Clinical High Risk of Psychosis Schizophrenia Bulletin. 43: S100-S101. DOI: 10.1093/Schbul/Sbx021.270  0.37
2017 Burrell H, Lawson M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Jeffries C, Mathalon D, McGlashan T, Seidman L, Tsuang M, Walker E, Woods S, Perkins D. 155. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk Schizophrenia Bulletin. 43: S80-S80. DOI: 10.1093/Schbul/Sbx021.213  0.366
2017 Auther A, Carrion R, McLaughlin D, Addington J, Bearden C, Cadenhead K, Cannon T, Mathalon D, McGlashan TH, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Cornblatt B. 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth Schizophrenia Bulletin. 43: S53-S53. DOI: 10.1093/Schbul/Sbx021.138  0.356
2017 Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Roach B, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, et al. 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S45-S45. DOI: 10.1093/Schbul/Sbx021.119  0.346
2017 Jeffries C, Perkins D, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman LJ, Tsuang M, Walker E, Woods S. 59.4 Networks of Blood Analytes are Collectively Informative of Risk of Conversion to Schizophrenia Schizophrenia Bulletin. 43: S33-S33. DOI: 10.1093/Schbul/Sbx021.086  0.32
2017 Velthorst E, Bearden C, Addington J, Cadenhead K, Cannon T, Carrion R, Auther A, Cornblatt B, McGlashan T, Mathalon D, Perkins D, Tsuang M, Walker E, Woods S, Meyer E, et al. 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1 Schizophrenia Bulletin. 43: S23-S24. DOI: 10.1093/Schbul/Sbx021.061  0.326
2017 Cadenhead K, Addington J, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S. 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium Schizophrenia Bulletin. 43: S16-S16. DOI: 10.1093/Schbul/Sbx021.042  0.308
2017 Kelsven S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Walker E, Woods S, Cadenhead K. 20. Metabolic Abnormalities and Omega-3 Fatty Acids in Latinos at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S14-S15. DOI: 10.1093/Schbul/Sbx021.039  0.302
2016 Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, et al. Insights into psychosis risk from leukocyte microRNA expression. Translational Psychiatry. 6: e981. PMID 27959328 DOI: 10.1038/Tp.2016.148  0.317
2016 Browne J, Penn DL, Meyer-Kalos PS, Mueser KT, Estroff SE, Brunette MF, Correll CU, Robinson J, Rosenheck RA, Schooler N, Robinson DG, Addington J, Marcy P, Kane JM. Psychological well-being and mental health recovery in the NIMH RAISE early treatment program. Schizophrenia Research. PMID 27913160 DOI: 10.1016/J.Schres.2016.11.032  0.358
2016 Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, et al. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. Jama Psychiatry. PMID 27806157 DOI: 10.1001/Jamapsychiatry.2016.2479  0.429
2016 Addington J, Liu L, Perkins DO, Carrion RE, Keefe RS, Woods SW. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. Schizophrenia Bulletin. PMID 27798225 DOI: 10.1093/Schbul/Sbw152  0.342
2016 Kuang C, Buchy L, Barbato M, Makowski C, MacMaster FP, Bray S, Deighton S, Addington J. A pilot study of cognitive insight and structural covariance in first-episode psychosis. Schizophrenia Research. PMID 27720314 DOI: 10.1016/J.Schres.2016.09.036  0.305
2016 Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, S Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-10. PMID 27705009 DOI: 10.1080/15374416.2016.1212361  0.423
2016 Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. The American Journal of Psychiatry. appiajp201615070890. PMID 27363508 DOI: 10.1176/Appi.Ajp.2016.15070890  0.372
2016 Buchy L, Mathalon DH, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Research. 254: 3-9. PMID 27289213 DOI: 10.1016/J.Pscychresns.2016.06.001  0.305
2016 Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Research. 242: 61-66. PMID 27259137 DOI: 10.1016/J.Psychres.2016.05.005  0.347
2016 Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophrenia Research. PMID 27165121 DOI: 10.1016/J.Schres.2016.04.041  0.357
2016 McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, et al. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophrenia Bulletin. PMID 27105902 DOI: 10.1093/Schbul/Sbw039  0.391
2016 Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophrenia Research. PMID 26905038 DOI: 10.1016/J.Schres.2016.02.002  0.324
2016 Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, et al. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophrenia Research. PMID 26896388 DOI: 10.1016/J.Schres.2016.02.003  0.389
2016 Drake RJ, Addington J, Viswanathan AC, Lewis SW, Cotter J, Yung AR, Abel KM. How age and gender predict illness course in a first-episode nonaffective psychosis cohort. The Journal of Clinical Psychiatry. PMID 26890690 DOI: 10.4088/Jcp.14M09369  0.343
2016 Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Social Psychiatry and Psychiatric Epidemiology. PMID 26851943 DOI: 10.1007/S00127-016-1182-Y  0.412
2016 Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophrenia Research. PMID 26785807 DOI: 10.1016/J.Schres.2016.01.017  0.355
2016 Marulanda S, Addington J. Resilience in individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. 10: 212-9. PMID 25234104 DOI: 10.1111/Eip.12174  0.431
2015 Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophrenia Research. Cognition. 2: 133-139. PMID 27695675 DOI: 10.1016/J.Scog.2015.04.004  0.317
2015 Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, et al. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. Jama Psychiatry. 1-8. PMID 26719911 DOI: 10.1001/Jamapsychiatry.2015.2324  0.401
2015 Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Research. PMID 26626949 DOI: 10.1016/J.Psychres.2015.11.033  0.343
2015 Fusar-Poli P, Schultze-Lutter F, Cappucciati M, Rutigliano G, Bonoldi I, Stahl D, Borgwardt S, Riecher-Rössler A, Addington J, Perkins DO, Woods SW, McGlashan T, Lee J, Klosterkötter J, Yung AR, et al. The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophrenia Bulletin. PMID 26591006 DOI: 10.1093/Schbul/Sbv162  0.373
2015 Lyngberg K, Buchy L, Liu L, Perkins D, Woods S, Addington J. Patterns of premorbid functioning in individuals at clinical high risk of psychosis. Schizophrenia Research. PMID 26589390 DOI: 10.1016/J.Schres.2015.11.004  0.403
2015 Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. Bmc Psychiatry. 15: 276. PMID 26553191 DOI: 10.1186/S12888-015-0656-X  0.348
2015 McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Anxiety in youth at clinical high risk for psychosis. Early Intervention in Psychiatry. PMID 26456932 DOI: 10.1111/Eip.12274  0.352
2015 Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophrenia Research. PMID 26441004 DOI: 10.1016/J.Schres.2015.09.008  0.379
2015 Trampush JW, Lencz T, DeRosse P, John M, Gallego JA, Petrides G, Hassoun Y, Zhang JP, Addington J, Kellner CH, Tohen M, Burdick KE, Goldberg TE, Kane JM, Robinson DG, et al. Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophrenia Bulletin. PMID 26409223 DOI: 10.1093/Schbul/Sbv120  0.365
2015 Fusar-Poli P, Cappucciati M, Rutigliano G, Schultze-Lutter F, Bonoldi I, Borgwardt S, Riecher-Rössler A, Addington J, Perkins D, Woods SW, McGlashan TH, Lee J, Klosterkötter J, Yung AR, McGuire P. At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 322-32. PMID 26407788 DOI: 10.1002/Wps.20250  0.376
2015 Robinson DG, Gallego JA, John M, Petrides G, Hassoun Y, Zhang JP, Lopez L, Braga RJ, Sevy SM, Addington J, Kellner CH, Tohen M, Naraine M, Bennett N, Greenberg J, et al. A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. Schizophrenia Bulletin. PMID 26338693 DOI: 10.1093/Schbul/Sbv125  0.358
2015 Zhang JP, Robinson DG, Gallego JA, John M, Yu J, Addington J, Tohen M, Kane JM, Malhotra AK, Lencz T. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Schizophrenia Bulletin. PMID 26320194 DOI: 10.1093/Schbul/Sbv116  0.33
2015 Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophrenia Bulletin. 41: 1066-75. PMID 26272875 DOI: 10.1093/Schbul/Sbv091  0.361
2015 Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, et al. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. Jama Psychiatry. PMID 26267151 DOI: 10.1001/Jamapsychiatry.2015.0566  0.419
2015 Buchy L, Stowkowy J, MacMaster FP, Nyman K, Addington J. Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis. Psychiatry Research. 233: 418-23. PMID 26210694 DOI: 10.1016/J.Pscychresns.2015.07.010  0.336
2015 Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, et al. Demographic correlates of attenuated positive psychotic symptoms. Schizophrenia Research. PMID 25999040 DOI: 10.1016/J.Schres.2015.04.035  0.362
2015 Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. The Journal of Nervous and Mental Disease. 203: 328-35. PMID 25919383 DOI: 10.1097/Nmd.0000000000000290  0.354
2015 Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Core Schemas in Youth at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy. 1-11. PMID 25896713 DOI: 10.1017/S1352465815000144  0.381
2015 Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, Rosenheck RA, Addington J, Estroff SE, Robinson J, Penn DL, Robinson DG. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. The Journal of Clinical Psychiatry. 76: 240-6. PMID 25830446 DOI: 10.4088/Jcp.14M09289  0.366
2015 Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, Lynde DW, Gottlieb JD, Meyer-Kalos P, McGurk SR, Cather C, Saade S, Robinson DG, Schooler NR, Rosenheck RA, et al. The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components. Psychiatric Services (Washington, D.C.). 66: 680-90. PMID 25772766 DOI: 10.1176/Appi.Ps.201400413  0.309
2015 Robinson DG, Schooler NR, John M, Correll CU, Marcy P, Addington J, Brunette MF, Estroff SE, Mueser KT, Penn D, Robinson J, Rosenheck RA, Severe J, Goldstein A, Azrin S, et al. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. The American Journal of Psychiatry. 172: 237-48. PMID 25727536 DOI: 10.1176/Appi.Ajp.2014.13101355  0.336
2015 Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. Substance use in individuals at clinical high risk of psychosis. Psychological Medicine. 45: 2275-84. PMID 25727300 DOI: 10.1017/S0033291715000227  0.39
2015 Addington J, Heinssen RK, Robinson DG, Schooler NR, Marcy P, Brunette MF, Correll CU, Estroff S, Mueser KT, Penn D, Robinson JA, Rosenheck RA, Azrin ST, Goldstein AB, Severe J, et al. Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatric Services (Washington, D.C.). 66: 753-6. PMID 25588418 DOI: 10.1176/Appi.Ps.201400124  0.343
2015 Auther AM, Cadenhead KS, Carrión RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatrica Scandinavica. 132: 60-8. PMID 25572323 DOI: 10.1111/Acps.12382  0.37
2015 Piskulic D, Barbato M, Liu L, Addington J. Pilot study of cognitive remediation therapy on cognition in young people at clinical high risk of psychosis Psychiatry Research. 225: 93-98. PMID 25467705 DOI: 10.1016/J.Psychres.2014.10.021  0.336
2015 Addington J, Stowkowy J, Weiser M. Screening tools for clinical high risk for psychosis. Early Intervention in Psychiatry. 9: 345-56. PMID 25345316 DOI: 10.1111/Eip.12193  0.335
2015 Addington J, van der Gaag M. Psychosocial treatments for clinical high risk individuals. Schizophrenia Bulletin. 41: 22. PMID 25316912 DOI: 10.1093/Schbul/Sbu140  0.436
2015 Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophrenia Bulletin. 41: 419-28. PMID 25103207 DOI: 10.1093/Schbul/Sbu099  0.365
2015 Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biological Psychiatry. 77: 147-57. PMID 25034946 DOI: 10.1016/J.Biopsych.2014.05.023  0.413
2015 Deighton S, Addington J. Exercise practices in individuals at clinical high risk of developing psychosis. Early Intervention in Psychiatry. 9: 284-91. PMID 24252093 DOI: 10.1111/Eip.12107  0.354
2014 Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Marcy P, Addington J, Estroff SE, Robinson J, Penn DL, Azrin S, Goldstein A, Severe J, Heinssen R, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. Jama Psychiatry. 71: 1350-63. PMID 25321337 DOI: 10.1001/Jamapsychiatry.2014.1314  0.398
2014 Miklowitz DJ, O'Brien MP, Schlosser DA, Addington J, Candan KA, Marshall C, Domingues I, Walsh BC, Zinberg JL, De Silva SD, Friedman-Yakoobian M, Cannon TD. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 848-58. PMID 25062592 DOI: 10.1016/J.Jaac.2014.04.020  0.414
2014 Marshall C, Denny E, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J. The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Research. 219: 506-12. PMID 25048759 DOI: 10.1016/J.Psychres.2014.06.023  0.374
2014 Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophrenia Research. 158: 69-75. PMID 25012147 DOI: 10.1016/J.Schres.2014.06.022  0.385
2014 Stowkowy J, Perkins DO, Woods SW, Nyman K, Addington J. Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis. Behavioural and Cognitive Psychotherapy. 1-7. PMID 24949991 DOI: 10.1017/S1352465814000307  0.419
2014 Buchy L, Perkins D, Woods SW, Liu L, Addington J. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis. Schizophrenia Research. 156: 277-80. PMID 24837058 DOI: 10.1016/J.Schres.2014.04.021  0.353
2014 Yong E, Barbato M, Penn DL, Keefe RS, Woods SW, Perkins DO, Addington J. Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. Psychiatry Research. 218: 39-43. PMID 24755041 DOI: 10.1016/J.Psychres.2014.04.003  0.347
2014 Lecomte T, Corbière M, Ehmann T, Addington J, Abdel-Baki A, Macewan B. Development and preliminary validation of the First Episode Social Functioning Scale for early psychosis. Psychiatry Research. 216: 412-7. PMID 24613006 DOI: 10.1016/J.Psychres.2014.01.044  0.301
2014 Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention in Psychiatry. PMID 24576057 DOI: 10.1111/Eip.12128  0.411
2014 Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 40: 1452-61. PMID 24550526 DOI: 10.1093/Schbul/Sbt235  0.405
2014 Addington J, Shah H, Liu L, Addington D. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis. Schizophrenia Research. 153: 64-7. PMID 24439270 DOI: 10.1016/J.Schres.2013.12.014  0.376
2014 Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS. Substance use in clinical high risk for psychosis: a review of the literature. Early Intervention in Psychiatry. 8: 104-12. PMID 24224849 DOI: 10.1111/Eip.12100  0.396
2014 Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Research. 215: 52-60. PMID 24200216 DOI: 10.1016/J.Psychres.2013.10.006  0.429
2014 Barbato M, Addington J. Binocular depth perception in individuals at clinical high risk for psychosis: No evidence of dysfunction Neuropsychology. 28: 366-372. PMID 24188117 DOI: 10.1037/Neu0000033  0.373
2014 Saleem MM, Stowkowy J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. Perceived discrimination in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 8: 77-81. PMID 23773288 DOI: 10.1111/Eip.12058  0.368
2014 Barbato M, Penn DL, Perkins DO, Woods SW, Liu L, Addington J. Metacognitive functioning in individuals at clinical high risk for psychosis. Behavioural and Cognitive Psychotherapy. 42: 526-34. PMID 23517866 DOI: 10.1017/S1352465813000167  0.406
2014 Cadenhead K, Addington J, Bearden CE, Cannon T, McGlashan T, Mathalon D, Perkins D, Seidman LI, Tsuang M, Walker E, Woods S. Poster #T38 PREDICTION OF SYMPTOM OUTCOME IN CLINICAL HIGH RISK SUBJECTS USING THE ACOUSTIC STARTLE PARADIGM Schizophrenia Research. 153: S302-S303. DOI: 10.1016/S0920-9964(14)70855-2  0.339
2014 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LI, Valmaggia L, Cannon T, Velthorst E, Haan Ld, Cornblatt B, et al. The Psychosis High Risk State: Is It Valid? Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70075-1  0.333
2014 Piskulic D, Barbato M, Liu L, Addington J. Poster #M79 EFFECTS OF COGNITIVE REMEDIATION ON COGNITION IN YOUNG PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS Schizophrenia Research. 153: S218. DOI: 10.1016/S0920-9964(12)70739-9  0.336
2013 Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Development and Psychopathology. 25: 1171-86. PMID 24229556 DOI: 10.1017/S0954579413000448  0.43
2013 Healey KM, Penn DL, Perkins D, Woods SW, Addington J. Theory of mind and social judgments in people at clinical high risk of psychosis. Schizophrenia Research. 150: 498-504. PMID 24055202 DOI: 10.1016/J.Schres.2013.08.038  0.345
2013 Barbato M, Liu L, Penn DL, Keefe RS, Perkins DO, Woods SW, Addington J. Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. Schizophrenia Research. 150: 542-6. PMID 24012459 DOI: 10.1016/J.Schres.2013.08.015  0.318
2013 Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophrenia Research. 148: 99-104. PMID 23787224 DOI: 10.1016/J.Schres.2013.05.019  0.362
2013 Addington DE, Patten SB, McKenzie E, Addington J. Relationship between relapse and hospitalization in first-episode psychosis. Psychiatric Services (Washington, D.C.). 64: 796-9. PMID 23632466 DOI: 10.1176/Appi.Ps.201200440  0.307
2013 Stowkowy J, Addington J. Predictors of a clinical high risk status among individuals with a family history of psychosis. Schizophrenia Research. 147: 281-6. PMID 23611242 DOI: 10.1016/J.Schres.2013.03.030  0.399
2013 Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biological Psychiatry. 74: 410-7. PMID 23562006 DOI: 10.1016/J.Biopsych.2013.02.016  0.39
2013 Addington J, Stowkowy J, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Early traumatic experiences in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 7: 300-5. PMID 23343384 DOI: 10.1111/Eip.12020  0.41
2013 Magaud E, Nyman K, Addington J. Cyberbullying in those at clinical high risk for psychosis. Early Intervention in Psychiatry. 7: 427-30. PMID 23343259 DOI: 10.1111/Eip.12013  0.393
2013 Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research. 144: 43-50. PMID 23340377 DOI: 10.1016/J.Schres.2012.11.039  0.358
2013 Addington J. Identifying a treatable psychosis-risk cohort. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 58: 3-4. PMID 23327749 DOI: 10.1177/070674371305800102  0.491
2013 Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. Jama Psychiatry. 70: 107-20. PMID 23165428 DOI: 10.1001/Jamapsychiatry.2013.269  0.351
2013 Barbato M, Colijn MA, Keefe RS, Perkins DO, Woods SW, Hawkins KA, Christensen BK, Addington J. The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. Psychiatry Research. 206: 195-9. PMID 23159196 DOI: 10.1016/J.Psychres.2012.10.013  0.345
2013 Addington J, McGregor L, Marulanda D, Raedler T. Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis. Epidemiology and Psychiatric Sciences. 22: 181-5. PMID 23114021 DOI: 10.1017/S2045796012000583  0.359
2013 Brummitt K, Addington J. Treatment possibilities for individuals at clinical high risk of psychosis. Early Intervention in Psychiatry. 7: 155-61. PMID 22741811 DOI: 10.1111/J.1751-7893.2012.00370.X  0.39
2013 Stowkowy J, Colijn MA, Addington J. Pathways to care for those at clinical high risk of developing psychosis. Early Intervention in Psychiatry. 7: 80-3. PMID 22741608 DOI: 10.1111/J.1751-7893.2012.00368.X  0.324
2013 Boydell KM, Volpe T, Gladstone BM, Stasiulis E, Addington J. Youth at ultra high risk for psychosis: using the Revised Network Episode Model to examine pathways to mental health care. Early Intervention in Psychiatry. 7: 170-86. PMID 22390350 DOI: 10.1111/J.1751-7893.2012.00350.X  0.341
2012 Addington J, Barbato M. The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis Epidemiology and Psychiatric Sciences. 21: 335-342. PMID 23174394 DOI: 10.1017/S204579601200042X  0.362
2012 Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, et al. Whither the attenuated psychosis syndrome? Schizophrenia Bulletin. 38: 1130-4. PMID 23144056 DOI: 10.1093/Schbul/Sbs108  0.425
2012 Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophrenia Research. 142: 77-82. PMID 23043872 DOI: 10.1016/J.Schres.2012.09.012  0.35
2012 Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research. 196: 220-4. PMID 22445704 DOI: 10.1016/J.Psychres.2012.02.018  0.366
2012 Addington J, Lecomte T. Cognitive behaviour therapy for schizophrenia. F1000 Medicine Reports. 4: 6. PMID 22403587 DOI: 10.3410/M4-6  0.379
2012 Addington J, Marshall C, French P. Cognitive behavioral therapy in prodromal psychosis. Current Pharmaceutical Design. 18: 558-65. PMID 22239588 DOI: 10.2174/138161212799316082  0.33
2012 Addington J, Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annual Review of Clinical Psychology. 8: 269-89. PMID 22224837 DOI: 10.1146/Annurev-Clinpsy-032511-143146  0.436
2012 Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, et al. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophrenia Research. 134: 1-9. PMID 22056201 DOI: 10.1016/J.Schres.2011.10.005  0.358
2012 Marshall C, Addington J, Epstein I, Liu L, Deighton S, Zipursky RB. Treating young individuals at clinical high risk for psychosis. Early Intervention in Psychiatry. 6: 60-8. PMID 21951980 DOI: 10.1111/j.1751-7893.2011.00299.x  0.324
2012 Stowkowy J, Addington J. Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis. Early Intervention in Psychiatry. 6: 87-90. PMID 21951894 DOI: 10.1111/J.1751-7893.2011.00297.X  0.34
2012 Colijn MA, Barbato M, Keefe RS, Perkins DO, Woods SW, Addington J. Poster #143 AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION Schizophrenia Research. 136: S237. DOI: 10.1016/S0920-9964(12)70715-6  0.347
2012 Stowkowv l, Addington J. Poster #239 FAMILY HISTORY OF PSYCHOSIS, SOCIAL RISK FACTORS AND RISK OF DEVELOPING PSYCHOSIS Schizophrenia Research. 136: S177. DOI: 10.1016/S0920-9964(12)70552-2  0.362
2012 Piskulic D, Penn D, Perkins D, Woods S, Liu L, Addington J. Poster #162 AFFECT RECOGNITION IN PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136: S149-S150. DOI: 10.1016/S0920-9964(12)70476-0  0.371
2011 Menon M, Schmitz TW, Anderson AK, Graff A, Korostil M, Mamo D, Gerretsen P, Addington J, Remington G, Kapur S. Exploring the neural correlates of delusions of reference. Biological Psychiatry. 70: 1127-33. PMID 21831358 DOI: 10.1016/J.Biopsych.2011.05.037  0.312
2011 Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. The American Journal of Psychiatry. 168: 800-5. PMID 21498462 DOI: 10.1176/Appi.Ajp.2011.10081191  0.437
2011 Pencer A, Addington J. Reasons for using substances in adolescents with and without psychosis. Early Intervention in Psychiatry. 2: 42-4. PMID 21352130 DOI: 10.1111/J.1751-7893.2007.00055.X  0.772
2011 Addington J. The promise of early intervention. Early Intervention in Psychiatry. 1: 294-307. PMID 21352118 DOI: 10.1111/J.1751-7893.2007.00043.X  0.343
2011 Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research. 125: 54-61. PMID 21074974 DOI: 10.1016/J.Schres.2010.10.015  0.383
2010 Cadenhead KS, Addington J, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Heinssen R. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Intervention in Psychiatry. 4: 220-6. PMID 20712727 DOI: 10.1111/J.1751-7893.2010.00183.X  0.411
2010 Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Archives of General Psychiatry. 67: 578-88. PMID 20530007 DOI: 10.1016/J.Schres.2010.02.210  0.428
2010 Addington J, Piskulic D. Social cognition and functional outcome are separate domains in schizophrenia. Schizophrenia Research. 127: 262-3. PMID 20471225 DOI: 10.1016/J.Schres.2010.04.005  0.321
2010 Addington J, Girard TA, Christensen BK, Addington D. Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. Journal of Psychiatry & Neuroscience : Jpn. 35: 49-54. PMID 20040246 DOI: 10.1503/Jpn.080039  0.32
2010 Pencer A, Addington J. Models of substance use in adolescents with and without psychosis. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent. 17: 202-9. PMID 19018323  0.783
2010 Piskulic D, Addington J, Maruff P. SOCIAL COGNITION IN SCHIZOPHRENIA: A QUANTITATIVE REVIEW OF THE LITERATURE Schizophrenia Research. 117: 413-414. DOI: 10.1016/J.Schres.2010.02.760  0.312
2010 Holtzman CW, Larson MK, Addington J, Cadenhead K, Cannon TD, Cornblatt B, Heinssen R, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Woods SW, Walker EF. SEX DIFFERENCES IN SYMPTOM PRESENTATION IN INDIVIDUALS AT RISK FOR PSYCHOSIS Schizophrenia Research. 117: 304-305. DOI: 10.1016/J.Schres.2010.02.508  0.371
2010 Addington J, Cornblatt B, Cadenhead K, Cannon T, Heinssen R, McGlashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. CLINICAL HIGH RISK FOR PSYCHOSIS: THE RISK OF FALSE POSITIVE Schizophrenia Research. 117: 279. DOI: 10.1016/J.Schres.2010.02.452  0.367
2010 Mizrahi R, Addington J, Rusjan P, Ivonne S, Isabelle B, Ng A, Pruessner J, Remington G, Houle S, Wilson AA. STRESS-INDUCED DOPAMINE RELEASE IN SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS AND IN ANTIPSYCHOTIC NAIVE PATIENTS WITH PSYCHOSIS: A [11C]-(+)-PHNO PET STUDY Schizophrenia Research. 117: 173-174. DOI: 10.1016/J.Schres.2010.02.204  0.307
2010 Piskulic D, Addington J. SOCIAL COGNITION AND FUNCTIONAL OUTCOME AS SEPARATE DOMAINS IN SCHIZOPHRENIA Schizophrenia Research. 117: 528. DOI: 10.1016/J.Schres.2010.02.1017  0.331
2009 Addington J, Addington D. Three-year outcome of treatment in an early psychosis program. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 626-30. PMID 19751551 DOI: 10.1177/070674370905400907  0.349
2009 Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophrenia Research. 115: 50-7. PMID 19709859 DOI: 10.1016/J.Schres.2009.07.023  0.352
2009 Addington J, Mancuso E. Cognitive-behavioral therapy for individuals at high risk of developing psychosis. Journal of Clinical Psychology. 65: 879-90. PMID 19536867 DOI: 10.1002/Jclp.20609  0.379
2009 Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 35: 894-908. PMID 19386578 DOI: 10.1093/Schbul/Sbp027  0.404
2009 Addington J, Tran L. Using the brief core schema scales with individuals at clinical high risk of psychosis. Behavioural and Cognitive Psychotherapy. 37: 227-31. PMID 19364422 DOI: 10.1017/S1352465809005116  0.337
2008 Addington J, Epstein I, Reynolds A, Furimsky I, Rudy L, Mancini B, McMillan S, Kirsopp D, Zipursky RB. Early detection of psychosis: finding those at clinical high risk. Early Intervention in Psychiatry. 2: 147-53. PMID 21352147 DOI: 10.1111/J.1751-7893.2008.00078.X  0.366
2008 Addington J, Addington D. Symptom remission in first episode patients. Schizophrenia Research. 106: 281-5. PMID 18926666 DOI: 10.1016/J.Schres.2008.09.014  0.348
2008 Addington J, Addington D. Outcome after discharge from an early psychosis program. Schizophrenia Research. 106: 363-6. PMID 18829260 DOI: 10.1016/J.Schres.2008.08.032  0.337
2008 Hawkins KA, Keefe RS, Christensen BK, Addington J, Woods SW, Callahan J, Zipursky RB, Perkins DO, Tohen M, Breier A, McGlashan TH. Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophrenia Research. 105: 1-9. PMID 18774696 DOI: 10.1016/J.Schres.2008.07.008  0.39
2008 Mizrahi R, Addington J, Remington G, Kapur S. Attribution style as a factor in psychosis and symptom resolution Schizophrenia Research. 104: 220-227. PMID 18632256 DOI: 10.1016/J.Schres.2008.05.003  0.358
2008 Couture SM, Penn DL, Addington J, Woods SW, Perkins DO. Assessment of social judgments and complex mental states in the early phases of psychosis. Schizophrenia Research. 100: 237-41. PMID 18255273 DOI: 10.1016/J.Schres.2007.12.484  0.326
2008 Weiser M, Reichenberg A, Werbeloff N, Kravitz E, Halperin D, Lubin G, Shmushkevitch M, Yoffe R, Addington J, Davidson M. Self-report of family functioning and risk for psychotic disorders in male adolescents with behavioural disturbances. Acta Psychiatrica Scandinavica. 117: 225-31. PMID 18241305 DOI: 10.1111/J.1600-0447.2007.01143.X  0.376
2008 Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry. 65: 28-37. PMID 18180426 DOI: 10.1001/Archgenpsychiatry.2007.3  0.436
2008 Addington J, Penn D, Woods SW, Addington D, Perkins DO. Facial affect recognition in individuals at clinical high risk for psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 192: 67-8. PMID 18174514 DOI: 10.1192/Bjp.Bp.107.039784  0.402
2008 Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research. 99: 119-24. PMID 18023329 DOI: 10.1016/J.Schres.2007.10.001  0.376
2008 Mizrahi R, Addington J, Kapur S. ATTRIBUTION STYLE IS ASSOCIATED WITH SEVERITY OF PSYCHOTIC SYMPTOMS AND RECOVERY IN PRIMARY PSYCHOTIC DISORDERS Schizophrenia Research. 102: 215. DOI: 10.1016/S0920-9964(08)70649-2  0.316
2007 Hoffman RE, Woods SW, Hawkins KA, Pittman B, Tohen M, Preda A, Breier A, Glist J, Addington J, Perkins DO, McGlashan TH. Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. The British Journal of Psychiatry : the Journal of Mental Science. 191: 355-6. PMID 17906248 DOI: 10.1192/Bjp.Bp.106.031195  0.362
2007 Addington J, Addington D. Social and cognitive functioning in psychosis. Schizophrenia Research. 99: 176-81. PMID 17681756 DOI: 10.1016/J.Schres.2007.07.004  0.319
2007 Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM. Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin. 33: 868-76. PMID 17562692 DOI: 10.1093/Schbul/Sbm059  0.378
2007 McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, Penn D, Perkins D, Salokangas RK, Walsh B, Woods SW, Yung A. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophrenia Bulletin. 33: 715-26. PMID 17483100 DOI: 10.1093/Schbul/Sbm025  0.365
2007 McCleery A, Addington J, Addington D. Family assessment in early psychosis. Psychiatry Research. 152: 95-102. PMID 17449111 DOI: 10.1016/J.Psychres.2006.07.002  0.693
2007 Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica. 115: 304-9. PMID 17355521 DOI: 10.1111/J.1600-0447.2006.00900.X  0.329
2007 Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin. 33: 665-72. PMID 17255119 DOI: 10.1093/Schbul/Sbl075  0.41
2007 Addington J, McCleery A, Collins A, Addington D. Family Work in Early Psychosis Journal of Family Psychotherapy. 17: 137-153. DOI: 10.1300/J085V17N03_09  0.681
2006 Saeedi H, Addington J, Addington D. The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up. Schizophrenia Research. 89: 123-8. PMID 17097272 DOI: 10.1016/J.Schres.2006.09.018  0.384
2006 McCleery A, Addington J, Addington D. Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up. Schizophrenia Research. 88: 187-91. PMID 16942863 DOI: 10.1016/J.Schres.2006.06.040  0.697
2006 Addington J, Chaves A, Addington D. Diagnostic stability over one year in first-episode psychosis Schizophrenia Research. 86: 71-75. PMID 16750610 DOI: 10.1016/J.Schres.2006.04.018  0.388
2006 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. The American Journal of Psychiatry. 163: 790-9. PMID 16648318 DOI: 10.1176/Ajp.2006.163.5.790  0.358
2006 Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophrenia Research. 78: 35-43. PMID 15978781 DOI: 10.1016/J.Schres.2005.05.008  0.351
2006 Boydell K, Addington J, Goering P, McCay E, Krupa T, Gladstone B, Volpe T. 0469 YOUTH EXPERIENCING FIRST EPISODE PSYCHOSIS: A COMPREHENSIVE EXAMINATION OF PATHWAYS TO MENTAL HEALTH CARE Schizophrenia Research. 86: S124. DOI: 10.1016/S0920-9964(06)70372-3  0.302
2006 Hoffman RE, Woods S, Preda A, Tohen M, Breier A, Glist J, Addington J, Perkins DO, Hawkins K, McGlashan TH. Tc3A Excessive Top-Down Perceptual Processing And Reduced Real-World Investment Exhibited By Prodromal Patients Predict Subsequent Conversion To Schizophrenia Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70137-2  0.301
2006 Addington J, Haarmans M. Cognitive-Behavioral Therapy for Individuals Recovering from a First Episode of Psychosis Journal of Contemporary Psychotherapy. 36: 43-49. DOI: 10.1007/S10879-005-9005-6  0.367
2005 Addington J, Collins A, McCleery A, Addington D. The role of family work in early psychosis. Schizophrenia Research. 79: 77-83. PMID 16198240 DOI: 10.1016/J.Schres.2005.01.013  0.681
2005 Addington J, Gleeson J. Implementing cognitive-behavioural therapy for first-episode psychosis. The British Journal of Psychiatry. Supplement. 48: s72-6. PMID 16055812 DOI: 10.1192/Bjp.187.48.S72  0.346
2005 Addington J. Cannabis use increases the risk of young people developing psychotic symptoms, particularly if already predisposed. Evidence-Based Mental Health. 8: 87. PMID 16043629 DOI: 10.1136/Ebmh.8.3.87  0.391
2005 Addington J, Addington D. Clinical trials during the prodromal stage of schizophrenia. The American Journal of Psychiatry. 162: 1387. PMID 15994732 DOI: 10.1176/Appi.Ajp.162.7.1387  0.319
2005 Addington J, McCleery A, Addington D. Three-year outcome of family work in an early psychosis program. Schizophrenia Research. 79: 107-16. PMID 15907375 DOI: 10.1016/J.Schres.2005.03.019  0.695
2005 Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Research. 133: 35-43. PMID 15698675 DOI: 10.1016/J.Psychres.2004.10.004  0.796
2004 Addington J. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis. Cns Spectrums. 9: 588-94. PMID 15273651 DOI: 10.1017/S1092852900002753  0.397
2004 Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, Addington J, Woods SW. Factorial structure of the Scale of Prodromal Symptoms. Schizophrenia Research. 68: 339-47. PMID 15099615 DOI: 10.1016/S0920-9964(03)00053-7  0.353
2004 Mastrigt SV, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology. 39: 69-72. PMID 15022049 DOI: 10.1007/S00127-004-0713-0  0.369
2004 Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophrenia Research. 67: 213-7. PMID 14984880 DOI: 10.1016/S0920-9964(03)00047-1  0.372
2004 Hawkins KA, Addington J, Keefe RS, Christensen B, Perkins DO, Zipurksy R, Woods SW, Miller TJ, Marquez E, Breier A, McGlashan TH. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research. 67: 115-22. PMID 14984870 DOI: 10.1016/J.Schres.2003.08.007  0.362
2004 Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychological Medicine. 34: 277-84. PMID 14982133 DOI: 10.1017/S0033291703001156  0.322
2004 Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatrica Scandinavica. 109: 116-20. PMID 14725592 DOI: 10.1046/J.0001-690X.2003.00232.X  0.335
2004 Addington J, Young J, Addington D. Social outcome in early psychosis. Psychological Medicine. 33: 1119-24. PMID 12946096 DOI: 10.1017/S0033291703007815  0.32
2004 Addington J, van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophrenia Research. 62: 23-30. PMID 12765739 DOI: 10.1016/S0920-9964(02)00408-5  0.362
2003 Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry. 54: 453-64. PMID 12915290 DOI: 10.1016/S0006-3223(03)00321-4  0.31
2003 Quillams L, Addington J. Insight, knowledge, and beliefs about illness in first-episode psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 350. PMID 12866346 DOI: 10.1177/070674370304800516  0.308
2003 Addington J, Brooks BL, Addington D. Cognitive functioning in first episode psychosis: initial presentation. Schizophrenia Research. 62: 59-64. PMID 12765744 DOI: 10.1016/S0920-9964(02)00340-7  0.356
2003 Addington J, Leriger E, Addington D. Symptom outcome 1 year after admission to an early psychosis program. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 204-7. PMID 12728745 DOI: 10.1177/070674370304800309  0.337
2003 Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research. 61: 19-30. PMID 12648732 DOI: 10.1016/S0920-9964(02)00440-1  0.442
2003 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research. 61: 7-18. PMID 12648731 DOI: 10.1016/S0920-9964(02)00439-5  0.365
2003 Pencer A, Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry & Neuroscience : Jpn. 28: 48-54. PMID 12587850  0.78
2003 Addington J, Van Mastrigt S, Hutchinson J, Addington D. Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica. 106: 358-64. PMID 12366470 DOI: 10.1034/J.1600-0447.2002.02004.X  0.331
2003 McGlashan TH, Zipursky RB, Perkins DO, Addington J, Woods SW, Miller TJ, Lindborg S, Marquez E, Hawkins K, Hoffman RE, Tohen M, Breier A. Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results Schizophrenia Research. 60: 295. DOI: 10.1016/S0920-9964(03)80497-8  0.316
2002 Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, Beauclair L. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. Journal of Clinical Psychopharmacology. 22: 20-5. PMID 11799338 DOI: 10.1097/00004714-200202000-00004  0.344
2002 Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal. 25: 60-7. PMID 11529454 DOI: 10.1037/H0095049  0.332
2002 Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_14.X  0.343
2002 Addington J, Addington D. Diagnoses at the first psychotic episode and cognitive functioning Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_131.X  0.402
2002 Mintz A, Addington J, Addington D. Insight in early psychosis: a 1 year follow-up Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_130.X  0.378
2002 Pencer A, Addington J, Hogg L, Addington D. Longitudinal outcome of first episode psychosis in adolescence Acta Psychiatrica Scandinavica. 106: 69-106. DOI: 10.1034/J.1600-0447.106.S413.1_129.X  0.793
2001 Grant C, Addington J, Addington D, Konnert C. Social functioning in first- and multiepisode schizophrenia Canadian Journal of Psychiatry. 46: 746-749. PMID 11692978 DOI: 10.1177/070674370104600808  0.328
2001 Martens L, Addington J. The psychological well-being of family members of individuals with schizophrenia Social Psychiatry and Psychiatric Epidemiology. 36: 128-133. PMID 11465784 DOI: 10.1007/S001270050301  0.337
2001 Addington J, Addington D, Gasbarre L. Neurocognitive and social functioning in schizophrenia and other diagnoses. Schizophrenia Research. 48: 367-8. PMID 11295389 DOI: 10.1016/S0920-9964(00)00103-1  0.312
2001 Addington J, Addington D, Jones B, Ko T. Family intervention in an early psychosis program Psychiatric Rehabilitation Skills. 5: 272-286. DOI: 10.1080/15487760108415433  0.334
2000 Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research. 44: 47-56. PMID 10867311 DOI: 10.1016/S0920-9964(99)00160-7  0.316
1999 Addington D, Addington J, Robinson G. Attributional style and depression in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 44: 697-700. PMID 10500872 DOI: 10.1177/070674379904400708  0.33
1999 El-Guebaly N, Hodgins DC, Armstrong S, Addington J. Methodological and clinical challenges in evaluating treatment outcome of substance-related disorders and comorbidity Canadian Journal of Psychiatry. 44: 264-270. PMID 10225128 DOI: 10.1177/070674379904400307  0.3
1999 Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin. 25: 173-82. PMID 10098920 DOI: 10.1093/Oxfordjournals.Schbul.A033363  0.308
1999 Addington J, el-Guebaly N, Duchak V, Hodgins D. Using measures of readiness to change in individuals with schizophrenia. The American Journal of Drug and Alcohol Abuse. 25: 151-61. PMID 10078983 DOI: 10.1081/Ada-100101851  0.351
1999 Addington J, Addington D. Visual attention and symptoms in schizophrenia: a 1-year follow-up. Schizophrenia Research. 34: 95-9. PMID 9824881 DOI: 10.1016/S0920-9964(98)00074-7  0.325
1999 Addington J, el-Guebaly N. Group treatment for substance abuse in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 43: 843-5. PMID 9806092 DOI: 10.1177/070674379804300810  0.348
1998 Addington J, McCleary L, Munroe-Blum H. Relationship between cognitive and social dysfunction in schizophrenia. Schizophrenia Research. 34: 59-66. PMID 9824877 DOI: 10.1016/S0920-9964(98)00079-6  0.305
1998 Addington J, Addington D. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research. 32: 171-81. PMID 9720122 DOI: 10.1016/S0920-9964(98)00042-5  0.307
1998 Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services (Washington, D.C.). 49: 925-8. PMID 9661227 DOI: 10.1176/Ps.49.7.925  0.307
1998 Addington J, El-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia American Journal of Psychiatry. 155: 974-976. PMID 9659869 DOI: 10.1176/Ajp.155.7.974  0.308
1998 Addington J, Addington D. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 983. PMID 9429073 DOI: 10.1177/070674379704200919  0.308
1998 Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica. 96: 329-33. PMID 9395149 DOI: 10.1111/J.1600-0447.1997.Tb09925.X  0.353
1998 Addington J, Addington D. Effect of substance misuse in early psychosis British Journal of Psychiatry. 172: 134-136. DOI: 10.1192/S0007125000297791  0.385
1998 Addington D, Addington J, Patten S. Depression in people with first-episode schizophrenia British Journal of Psychiatry. 172: 90-92. DOI: 10.1192/S0007125000297729  0.364
1997 Addington J, Addington D. Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophrenia Research. 23: 197-204. PMID 9075297 DOI: 10.1016/S0920-9964(96)00105-3  0.324
1996 Addington D, Addington J, Atkinson M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia Research. 19: 205-12. PMID 8789919 DOI: 10.1016/0920-9964(95)00070-4  0.336
1996 Addington D, Addington J, Patten S. Course, correlates and predictors of depression in schizophrenia Schizophrenia Research. 18: 117. DOI: 10.1016/0920-9964(96)85399-0  0.329
1995 Addington J, Addington D. Cognitive and social functioning in schizophrenia Schizophrenia Research. 15: 107. DOI: 10.1016/0920-9964(95)95328-7  0.324
1995 Addington D, Addington J, Atkinson M. Factor analysis of depression scales in schizophrenia Schizophrenia Research. 15: 5. DOI: 10.1016/0920-9964(95)95025-5  0.309
1994 Addington D, Addington J, Maticka-Tyndale E. Specificity of the Calgary Depression Scale for schizophrenics Schizophrenia Research. 11: 239-244. PMID 8193062 DOI: 10.1016/0920-9964(94)90017-5  0.324
1993 ADDINGTON D, ADDINGTON J, MATICKA-TYNDALE E. Rating Depression in Schizophrenia The Journal of Nervous and Mental Disease. 181: 561-565. DOI: 10.1097/00005053-199309000-00006  0.318
1991 Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia Schizophrenia Research. 5: 123-134. PMID 1931805 DOI: 10.1016/0920-9964(91)90039-T  0.352
1991 Addington J, Addington D. Positive and negative symptoms of schizophrenia. Their course and relationship over time. Schizophrenia Research. 5: 51-9. PMID 1854677 DOI: 10.1016/0920-9964(91)90053-T  0.332
1991 Addington J, Addington D. Gender differences in cognitive functioning and symptoms in schizophrenics Schizophrenia Research. 4: 273. DOI: 10.1016/0920-9964(91)90135-E  0.322
Low-probability matches (unlikely to be authored by this person)
2024 Healy C, Byrne J, Raj Suasi S, Föcking M, Mongan D, Kodosaki E, Heurich-Sevcenco M, Cagney G, Wynne K, Bearden CE, Woods SW, Cornblatt B, Mathalon D, Stone W, Cannon TD, ... Addington J, et al. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms. Brain, Behavior, and Immunity. PMID 38219978 DOI: 10.1016/j.bbi.2023.12.018  0.3
1993 Addington J, Addington D. Visual attention and positive and negative symptoms of schizophrenia Schizophrenia Research. 9: 171. DOI: 10.1016/0920-9964(93)90325-D  0.3
2023 Tronick LN, Mirzakhanian H, Addington J, Bearden CE, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. Early Intervention in Psychiatry. PMID 36627192 DOI: 10.1111/eip.13369  0.299
2004 Addington J, Coldham EL, Jones B, Ko T, Addington D. The first episode of psychosis: the experience of relatives. Acta Psychiatrica Scandinavica. 108: 285-9. PMID 12956829 DOI: 10.1034/J.1600-0447.2003.00153.X  0.299
2012 Addington J, Piskulic D, Perkins D, Woods SW, Liu L, Penn DL. Affect recognition in people at clinical high risk of psychosis. Schizophrenia Research. 140: 87-92. PMID 22763425 DOI: 10.1016/J.Schres.2012.06.012  0.299
2020 Worthington MA, Miklowitz DJ, O'Brien M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. Early Intervention in Psychiatry. PMID 31943807 DOI: 10.1111/Eip.12914  0.298
2021 Koutsouleris N, Worthington M, Dwyer DB, Kambeitz-Ilankovic L, Sanfelici R, Fusar-Poli P, Rosen M, Ruhrmann S, Anticevic A, Addington J, Perkins DO, Bearden CE, Cornblatt BA, Cadenhead KS, Mathalon DH, et al. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort. Biological Psychiatry. PMID 34482951 DOI: 10.1016/j.biopsych.2021.06.023  0.297
2019 Kelsven S, Holden J, Devoe D, Addington J, Auther A, Kali B, Cadenhead KS, Cornblatt B, Santesteban-Echarri O, Granholm E. S102. COGNITIVE-BEHAVIORAL SOCIAL SKILLS TRAINING IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS: QUANTITATIVE AND QUALITATIVE METHODS: FOR IMPLEMENTATION AND FACILITATOR TRAINING Schizophrenia Bulletin. 45: S345-S346. DOI: 10.1093/Schbul/Sbz020.647  0.297
2006 Seidman L, Cornblatt B, Addington J, Cadenhead K, Cannon T, McGlashan T, Perkins D, Walker E, Woods S, Tsuang M, Heinssen R. WC8B NEUROCOGNITIVE FUNCTIONING IN THE PRODROME TO PSYCHOSIS FROM THE NAPLS COLLABORATION Schizophrenia Research. 86: S17. DOI: 10.1016/S0920-9964(06)70051-2  0.296
2024 Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, et al. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 38451304 DOI: 10.1093/schbul/sbae011  0.296
2016 Buchy L, Barbato M, MacMaster FP, Bray S, Clark D, Deighton S, Addington J. Cognitive insight is associated with cortical thickness in first-episode psychosis. Schizophrenia Research. PMID 26899212 DOI: 10.1016/J.Schres.2016.02.026  0.296
2018 Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, et al. Networks of blood proteins in the neuroimmunology of schizophrenia. Translational Psychiatry. 8: 112. PMID 29875399 DOI: 10.1038/S41398-018-0158-Y  0.294
2022 Santesteban-Echarri O, Liu L, Miller M, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, ... ... Addington J, et al. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis. Schizophrenia Research. 248: 114-121. PMID 36030758 DOI: 10.1016/j.schres.2022.08.005  0.294
2023 Devoe DJ, Lui L, Cannon TD, Cadenhead KS, Cornblatt BA, Keshavan M, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, ... Addington J, et al. The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis. Frontiers in Psychiatry. 14: 1125168. PMID 37293402 DOI: 10.3389/fpsyt.2023.1125168  0.292
1986 Addington J, Fry PS. 5/Directions for Clinical-Psychosocial Assessment of Depression in the Elderly Clinical Gerontologist. 5: 97-117. DOI: 10.1300/J018V05N01_05  0.292
2012 Addington J. International Early Psychosis Association. Early Intervention in Psychiatry. 6: 355-6. PMID 23107577 DOI: 10.1111/Eip.12006  0.291
2019 LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. Stress perception following childhood adversity: Unique associations with adversity type and sex. Development and Psychopathology. 1-14. PMID 30846020 DOI: 10.1017/S0954579419000130  0.291
2019 Sutcliff J, Dixon HD, Johannesen J, Davidson C, Roach B, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, et al. S57. Does the Acquisition of Social Cognitive Skills Over Adolescence Coincide With Neurophysiological Metric of Brain Maturation? A Cross-Sectional Analysis of the NAPLS-II Consortium Sample Biological Psychiatry. 85: S318-S319. DOI: 10.1016/J.Biopsych.2019.03.808  0.29
2020 Devoe DJ, Braun A, Seredynski T, Addington J. Negative Symptoms and Functioning in Youth at Risk of Psychosis: A Systematic Review and Meta-analysis. Harvard Review of Psychiatry. 28: 341-355. PMID 33156155 DOI: 10.1097/HRP.0000000000000273  0.289
2003 Hawkins KA, McGlashan T, Keefe R, Christensen B, Addington J, Marquez E, Breier A. Neuropsychological status of the first-episode prodrome Schizophrenia Research. 60: 4. DOI: 10.1016/S0920-9964(03)80008-7  0.289
2020 Cao H, Chen OY, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, et al. Cross-paradigm connectivity: reliability, stability, and utility. Brain Imaging and Behavior. PMID 32361945 DOI: 10.1007/S11682-020-00272-Z  0.288
1993 Addington D, Addington J, Maticka-tyndale E. Assessing Depression in Schizophrenia: The Calgary Depression Scale British Journal of Psychiatry. 163: 39-44. DOI: 10.1192/S0007125000292581  0.288
2024 Cowan HR, Mittal VA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang MT, Woods SW, Cannon TD, Walker EF. Longitudinal Trajectories of Premorbid Social and Academic Adjustment in Youth at Clinical High Risk for Psychosis: Implications for Conversion. Schizophrenia Bulletin. PMID 38706103 DOI: 10.1093/schbul/sbae050  0.288
2023 Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, ... ... Addington J, et al. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Early Intervention in Psychiatry. PMID 37641537 DOI: 10.1111/eip.13457  0.288
2023 Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, ... ... Addington J, et al. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Medrxiv : the Preprint Server For Health Sciences. PMID 37205422 DOI: 10.1101/2023.04.29.23289226  0.288
2015 Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, et al. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Molecular Neuropsychiatry. 1: 13-22. PMID 26005673 DOI: 10.1159/000371887  0.288
2013 Menon M, Addington J, Remington G. Examining cognitive biases in patients with delusions of reference. European Psychiatry : the Journal of the Association of European Psychiatrists. 28: 71-3. PMID 21658918 DOI: 10.1016/J.Eurpsy.2011.03.005  0.288
2017 Chung Y, Haut K, He G, Erp TV, McEwen S, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, et al. 83. Ventricular Enlargement and Progressive Reduction in Cortical Gray Matter Are Linked in Prodromal Youth Who Develop Psychosis Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.122  0.287
2022 Braun A, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, ... Addington J, et al. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort. Social Psychiatry and Psychiatric Epidemiology. PMID 35113189 DOI: 10.1007/s00127-022-02239-5  0.286
1997 Addington J, el-Guebaly N, Addington D, Hodgins D. Readiness to stop smoking in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 42: 49-52. PMID 9040923 DOI: 10.1177/070674379704200107  0.286
2012 Stowkowy J, Addington D, Liu L, Hollowell B, Addington J. Predictors of disengagement from treatment in an early psychosis program. Schizophrenia Research. 136: 7-12. PMID 22336955 DOI: 10.1016/J.Schres.2012.01.027  0.286
2012 Stowkowy J, Addington D, Liu L, Hollowell B, Addington J. Poster #183 PREDICTORS OF DISENGAGEMENT FROM TREATMENT IN AN EARLY PSYCHOSIS PROGRAM Schizophrenia Research. 136: S346-S347. DOI: 10.1016/S0920-9964(12)71015-0  0.285
2010 Jones EM, Trotman H, Esterberg ML, Brasfield J, Walker EF, Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Woods SW, Heinssen R. PRODROMAL SYMPTOMS: DIFFERENTIAL EFFECTS OF SEX AND FAMILY HISTORY Schizophrenia Research. 117: 197. DOI: 10.1016/J.Schres.2010.02.262  0.284
2006 Addington J, Saeedi H, Addington D. Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophrenia Research. 85: 142-50. PMID 16678388 DOI: 10.1016/J.Schres.2006.03.028  0.284
2003 Voges MA, Addington J, Young J, Addington D. Social outcome in early psychosis: A two year follow-up Schizophrenia Research. 60: 29. DOI: 10.1016/S0920-9964(03)80085-3  0.284
2016 Fusar-Poli P, Schultze-Lutter F, Addington J. Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution. The Lancet. Psychiatry. 3: 18. PMID 26772061 DOI: 10.1016/S2215-0366(15)00491-5  0.283
2018 Perkins D, Clark J, Addington J, Beardon C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Walker E, Woods S. 39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 44: S62-S62. DOI: 10.1093/Schbul/Sby014.159  0.283
2023 Amir CM, Kapler S, Hoftman GD, Kushan L, Zinberg J, Cadenhead KS, Kennedy L, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, ... ... Addington J, et al. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis. Frontiers in Psychiatry. 14: 1143315. PMID 37151981 DOI: 10.3389/fpsyt.2023.1143315  0.283
2007 Addington DE, McKenzie E, Addington J, Patten S, Smith H, Adair C. Performance measures for evaluating services for people with a first episode of psychosis Early Intervention in Psychiatry. 1: 157-167. DOI: 10.1111/J.1751-7893.2007.00020.X  0.282
2016 Mueser KT, Kim M, Addington J, McGurk SR, Pratt SI, Addington DE. Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised. Schizophrenia Research. PMID 27756514 DOI: 10.1016/J.Schres.2016.10.018  0.281
2019 Brodey BB, Girgis RR, Favorov OV, Bearden CE, Woods SW, Addington J, Perkins DO, Walker EF, Cornblatt BA, Brucato G, Purcell SE, Brodey IS, Cadenhead KS. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning. Schizophrenia Research. PMID 30777603 DOI: 10.1016/J.Schres.2019.01.015  0.281
2013 Suridjan I, Rusjan P, Addington J, Wilson AA, Houle S, Mizrahi R. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task. Journal of Psychiatry & Neuroscience : Jpn. 38: 98-106. PMID 23010256 DOI: 10.1503/Jpn.110181  0.28
2018 Mueser KT, Meyer-Kalos PS, Glynn SM, Lynde DW, Robinson DG, Gingerich S, Penn DL, Cather C, Gottlieb JD, Marcy P, Wiseman JL, Potretzke S, Brunette MF, Schooler NR, Addington J, et al. Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study. Schizophrenia Research. PMID 30139553 DOI: 10.1016/J.Schres.2018.08.015  0.279
2006 Cornblatt B, Addington J, Cadenhead K, Cannon T, Perkins D, Seidman L, Walker E, Woods S, McGlashan T, Tsaung M, Heinssen R. WC8C NAPLS CONSORTIUM: IMPAIRED SOCIAL, SCHOOL, AND WORK FUNCTIONING CHARACTERIZES PRODROMAL INDIVIDUALS PRIOR TO EMERGENCE OF PSYCHOSIS Schizophrenia Research. 86: S18. DOI: 10.1016/S0920-9964(06)70052-4  0.279
2011 Marshall C, Falukozi E, Albertin M, Zhu H, Addington J. The development of the Content of Attenuated Positive Symptoms Codebook for those at clinical high risk of psychosis. Psychosis. 4: 191-202. PMID 26161138 DOI: 10.1080/17522439.2011.626070  0.278
2021 Ku BS, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Compton MT, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Druss BG. Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophrenia Research. 238: 137-144. PMID 34673386 DOI: 10.1016/j.schres.2021.09.025  0.277
2018 Santesteban-Echarri O, Stowkowy J, Woods SW, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Addington JM. F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2) Schizophrenia Bulletin. 44: S231-S231. DOI: 10.1093/Schbul/Sby017.563  0.277
2023 Addington J, Woods SW, Yung AR, Calkins ME, Fusar-Poli P. Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS): An initial approach. Early Intervention in Psychiatry. PMID 36646443 DOI: 10.1111/eip.13401  0.277
2003 Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Olanzapine versus placebo for prodromal symptoms Schizophrenia Research. 60: 306-307. DOI: 10.1016/S0920-9964(03)80236-0  0.276
2022 Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrión RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. Jama Psychiatry. PMID 35675082 DOI: 10.1001/jamapsychiatry.2022.1417  0.276
2005 Voges M, Addington J. The association between social anxiety and social functioning in first episode psychosis. Schizophrenia Research. 76: 287-92. PMID 15949660 DOI: 10.1016/J.Schres.2005.01.001  0.275
2005 Addington J, Addington D. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome. Acta Psychiatrica Scandinavica. 112: 40-6. PMID 15952944 DOI: 10.1111/J.1600-0447.2005.00511.X  0.273
2012 Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin. 38: 1247-57. PMID 22080497 DOI: 10.1093/Schbul/Sbr136  0.273
2021 Miklowitz DJ, Addington JM, O'Brien MP, Denenny DM, Weintraub MJ, Zinberg JL, Mathalon DH, Cornblatt BA, Friedman-Yakoobian MS, Stone WS, Cadenhead KS, Woods SW, Sugar CA, Cannon TD, Bearden CE. Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial. Early Intervention in Psychiatry. PMID 34427047 DOI: 10.1111/eip.13208  0.273
2005 Addington J, Amminger GP, Barbato A, Catts S, Chen E, Chhim S, Chong SA, Cullberg J, Edwards J, Grosso L, Louzã M, Hambrecht M, Keshavan M, Johannessen JO, Johnson DL, et al. International clinical practice guidelines for early psychosis British Journal of Psychiatry. 187: s120-s124. DOI: 10.1192/Bjp.187.48.S120  0.272
2007 Chaves AC, Addington J, Seeman M, Addington D. One-year stability of diagnosis in first-episode nonaffective psychosis: influence of sex. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 51: 711-4. PMID 17121170 DOI: 10.1177/070674370605101108  0.27
2024 Sloan M, Sturner R, Addington J, Cornblatt B, Granholm E, Cadenhead KS. Negative self-reference as a component of subthreshold psychotic symptoms in clinical high-risk youth. Early Intervention in Psychiatry. PMID 38334214 DOI: 10.1111/eip.13515  0.27
2021 Collins MA, Chung Y, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis. Neuroimage. Clinical. 31: 102757. PMID 34273790 DOI: 10.1016/j.nicl.2021.102757  0.27
2016 Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, et al. Multisite Reliability of MR-Based Functional Connectivity. Neuroimage. PMID 27746386 DOI: 10.1016/J.Neuroimage.2016.10.020  0.269
2014 Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, Remington G, Houle S, Wilson AA. Exaggerated Dopamine Release In Immigrants During Social Stress: A Risk Mechanism For Psychosis Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70096-9  0.269
2005 Addington D, McKenzie E, Addington J, Patten S, Smith H, Adair C. Performance measures for early psychosis treatment services. Psychiatric Services (Washington, D.C.). 56: 1570-82. PMID 16339620 DOI: 10.1176/Appi.Ps.56.12.1570  0.268
1992 Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics Schizophrenia Research. 6: 201-208. PMID 1571313 DOI: 10.1016/0920-9964(92)90003-N  0.268
2007 Addington J, Saeedi H, Addington D. Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 189: 373-8. PMID 17012662 DOI: 10.1192/Bjp.Bp.105.021022  0.267
2022 Farris MS, Braun A, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD, ... Addington J, et al. Longitudinal impact of trauma in the North American Prodrome Longitudinal Study-3. Early Intervention in Psychiatry. PMID 35152553 DOI: 10.1111/eip.13270  0.267
2008 McGlashan T, Heinssen R, Seidman L, Tsuang M, Perkins D, Woods S, Cadenhead K, Cannon T, Walker E, Cornblatt B, Addington J. Advances in early detection, treatment and prevention: Findings from the North American Prodrome Longitudinal Study Schizophrenia Research. 98: 9. DOI: 10.1016/J.Schres.2007.12.014  0.266
2021 Santesteban-Echarri O, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up. Schizophrenia Research. 236: 87-88. PMID 34425382 DOI: 10.1016/j.schres.2021.08.014  0.266
2023 Tran T, Spilka MJ, Raugh IM, Strauss GP, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, ... ... Addington JM, et al. Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status. Schizophrenia Bulletin Open. 4: sgad014. PMID 37362552 DOI: 10.1093/schizbullopen/sgad014  0.265
1997 Addington J, Addington D, el-Guebaly N, Campbell W, Hodgins D. Smoking cessation treatment in schizophrenia Biological Psychiatry. 42: 232. DOI: 10.1016/S0006-3223(97)87853-5  0.265
2014 Cannon TD, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, ... ... Addington J, et al. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Human Brain Mapping. 35: 2424-34. PMID 23982962 DOI: 10.1002/Hbm.22338  0.264
2021 Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 34581405 DOI: 10.1093/schbul/sbab115  0.264
2006 Addington J, Addington D. Early intervention for psychosis: who refers? Schizophrenia Research. 84: 176-7. PMID 16546354 DOI: 10.1016/J.Schres.2006.01.014  0.263
2021 Devoe DJ, Cadenhead KS, Cornblatt B, Granholm E, Addington J. Negative symptoms: associations with defeatist beliefs, self-efficacy, and maladaptive schemas in youth and young adults at-risk for psychosis. Behavioural and Cognitive Psychotherapy. 1-14. PMID 34784991 DOI: 10.1017/S1352465821000461  0.262
2003 Addington J. The prodromal stage of psychotic illness: observation, detection or intervention? Journal of Psychiatry & Neuroscience : Jpn. 28: 93-7. PMID 12670126  0.262
2019 Cao H, Chung Y, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión R, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, et al. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophrenia Research. PMID 30704864 DOI: 10.1016/J.Schres.2019.01.017  0.262
2021 Braun A, Santesteban-Echarri O, Cadenhead KS, Cornblatt BA, Granholm E, Addington J. Bullying and social functioning, schemas, and beliefs among youth at clinical high risk for psychosis. Early Intervention in Psychiatry. PMID 33938145 DOI: 10.1111/eip.13157  0.262
2003 Addington J, Mansley C, Addington D. Weight gain in first-episode psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 272-6. PMID 12776395 DOI: 10.1177/070674370304800412  0.262
2023 Michaels TI, Carrión RE, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, et al. Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis. Schizophrenia Research. 254: 125-132. PMID 36857950 DOI: 10.1016/j.schres.2023.02.021  0.261
2008 Cornblatt B, Addington J, Seidman L, Walker E, Walker E, Cadenhead K, Cannon T, McGlashan T, Perkins D, Woods S, Heinssen R. NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS Schizophrenia Research. 102: 24. DOI: 10.1016/S0920-9964(08)70074-4  0.261
2022 Deng W, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Cannon TD. Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. Psychological Medicine. 1-8. PMID 35144716 DOI: 10.1017/S0033291722000277  0.259
2021 Deng W, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Joormann J, Cannon T. Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis. Psychiatric Research and Clinical Practice. 3: 163-171. PMID 36101655 DOI: 10.1176/appi.prcp.20210023  0.259
2018 Cao H, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, et al. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms. Cerebral Cortex (New York, N.Y. : 1991). PMID 29522112 DOI: 10.1093/Cercor/Bhy032  0.258
2020 Mathalon D, Roach B, Ford J, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, et al. Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and the Psychosis Risk Syndrome Biological Psychiatry. 87: S97-S98. DOI: 10.1016/J.Biopsych.2020.02.270  0.258
2016 Rosenheck R, Leslie D, Sint K, Lin H, Robinson DG, Schooler NR, Mueser KT, Penn DL, Addington J, Brunette MF, Correll CU, Estroff SE, Marcy P, Robinson J, Severe J, et al. Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program. Schizophrenia Bulletin. PMID 26834024 DOI: 10.1093/Schbul/Sbv224  0.257
2018 Guillory S, Velthorst E, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, Cornblatt B, et al. F202. Atypical P300 Amplitude Differentiates Conversion Patterns in Psychosis Prodrome When Autism Spectrum Disorder is Comorbid Biological Psychiatry. 83: S317-S318. DOI: 10.1016/J.Biopsych.2018.02.816  0.257
2022 Kelsven S, Brummit K, Devoe D, Santesteban-Echarri O, Auther A, Cornblatt B, Cadenhead K, Granholm E, Holden J, Kelly M, Addington J. Cognitive-Behavioral Social Skills Training Adapted for Youth at Clinical High Risk for Psychosis. Journal of Cognitive Psychotherapy. PMID 35470152 DOI: 10.1891/JCP-2021-0029  0.257
2005 Addington J. 4th International Conference on Early Psychosis: ‘Translating the Evidence’ Schizophrenia Research. 79: 1-4. DOI: 10.1016/J.Schres.2005.06.006  0.257
2015 Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, et al. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Human Brain Mapping. 36: 2558-79. PMID 25821147 DOI: 10.1002/Hbm.22791  0.257
2020 Santesteban-Echarri O, Haffey P, Kim G, Tang J, Addington J. A mobile-based app to monitor cannabis use among youth at clinical high risk (CHR) for psychosis: Feasibility and acceptability of LooseLeaf. Schizophrenia Research. PMID 32522468 DOI: 10.1016/j.schres.2020.05.031  0.256
1997 Hodgins DC, El-Guebaly N, Addington J. Treatment of substance abusers: Single or mixed gender programs? Addiction. 92: 805-812. PMID 9293039 DOI: 10.1111/J.1360-0443.1997.Tb02949.X  0.256
2023 Anglin DM, Espinosa A, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang M, Woods SW, Walker E, Bearden CE, Ku BS. Association of Childhood Area-Level Ethnic Density and Psychosis Risk Among Ethnoracial Minoritized Individuals in the US. Jama Psychiatry. PMID 37585191 DOI: 10.1001/jamapsychiatry.2023.2841  0.256
2014 Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, et al. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 97: 41-52. PMID 24736173 DOI: 10.1016/J.Neuroimage.2014.04.027  0.254
2023 Hagler MA, Ferrara M, Yoviene Sykes LA, Li F, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, Powers AR, et al. Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosis. Schizophrenia Research. 255: 239-245. PMID 37028205 DOI: 10.1016/j.schres.2023.03.047  0.254
2006 Addington D, Addington J, Patten S, Adair C, Mckenzie E, Smith H. 0004 EVALUATING EARLY PSYCHOSIS TREATMENT SERVICES WITH PERFORMANCE MEASURES Schizophrenia Research. 86: S169. DOI: 10.1016/S0920-9964(06)70510-2  0.254
2023 Bannai D, Reuter M, Hegde R, Hoang D, Adhan I, Gandu S, Pong S, Raymond N, Zeng V, Chung Y, He G, Sun D, van Erp TGM, Addington J, Bearden CE, et al. Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk for psychosis: A multisite neuroimaging study. Brain, Behavior, and Immunity. PMID 38169244 DOI: 10.1016/j.bbi.2023.12.021  0.252
2023 Aberizk K, Sefik E, Addington J, Anticevic A, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF. Hippocampal Connectivity with the Default Mode Network is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals. Clinical Psychological Science : a Journal of the Association For Psychological Science. 11: 801-818. PMID 37981950 DOI: 10.1177/21677026221138819  0.252
2021 Addington J, Santesteban-Echarri O, Braun A, Lecomte T. Assessing social functioning in youth at clinical high-risk for psychosis. Schizophrenia Research. 228: 188-189. PMID 33444935 DOI: 10.1016/j.schres.2020.12.017  0.251
2020 Rinne GR, O'Brien MP, Miklowitz DJ, Addington JM, Cannon TD. Depression, family interaction and family intervention in adolescents at clinical-high risk for psychosis. Early Intervention in Psychiatry. PMID 32232954 DOI: 10.1111/eip.12954  0.25
2024 Ruiz-Yu B, Le TP, Weintraub MJ, Zinberg J, Addington J, O'Brien MP, Walsh BC, Friedman-Yakoobian M, Auther A, Domingues I, Cannon TD, Miklowitz DJ, Bearden CE. Race/ethnicity and socioeconomic status as predictors of outcome following family therapy in youth at clinical high risk for psychosis. Early Intervention in Psychiatry. PMID 38676463 DOI: 10.1111/eip.13541  0.249
2020 Worthington MA, Walker EF, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophrenia Research. PMID 33046334 DOI: 10.1016/j.schres.2020.09.022  0.248
2017 Buchy L, Barbato M, Makowski C, Bray S, MacMaster FP, Deighton S, Addington J. Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study. Schizophrenia Research. PMID 28169088 DOI: 10.1016/J.Schres.2017.01.054  0.248
2016 McAusland L, Addington J. Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis. Early Intervention in Psychiatry. PMID 27573093 DOI: 10.1111/eip.12368  0.248
2019 Sykes LY, Ferrara M, Cahill J, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Perkins D, Mathalon D, Seidman L, Tsuang M, Walker E, Powers A, McGlashan T, et al. F61. TRIVIAL TRANSITIONS? SIPS-DEFINED CONVERSIONS TO PSYCHOSIS: ONE YEAR OUTCOME Schizophrenia Bulletin. 45: S277-S278. DOI: 10.1093/Schbul/Sbz018.473  0.247
2010 McGorry P, Johanessen JO, Lewis S, Birchwood MJ, Malla A, Nordentoft M, Addington J, Yung A. Early intervention in psychosis: keeping faith with evidence-based health care Psychological Medicine. 40: 399-404. PMID 19775497 DOI: 10.1017/S0033291709991346  0.246
2014 Buchy L, Stowkowy J, MacMaster FP, Nyman K, Addington J. Meta-cognition is associated with cortical thickness in youth at clinical high risk of psychosis Psychiatry Research - Neuroimaging. DOI: 10.1016/j.pscychresns.2015.07.010  0.246
2002 Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica. 106: 286-90. PMID 12225495 DOI: 10.1034/J.1600-0447.2002.02437.X  0.245
2012 Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, Remington G, Houle S, Wilson AA. Increased stress-induced dopamine release in psychosis. Biological Psychiatry. 71: 561-7. PMID 22133268 DOI: 10.1016/J.Biopsych.2011.10.009  0.245
2020 Addington J, Farris M, Devoe D, Metzak P. Progression from being at-risk to psychosis: next steps. Npj Schizophrenia. 6: 27. PMID 33020486 DOI: 10.1038/s41537-020-00117-0  0.243
2021 O'Donoghue B, Geros H, Sizer H, Addington J, Amminger GP, Beaden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Berger GE, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Ising HK, et al. The association between migrant status and transition in an ultra-high risk for psychosis population. Social Psychiatry and Psychiatric Epidemiology. PMID 33399885 DOI: 10.1007/s00127-020-02012-6  0.243
2013 Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, et al. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 24: 626-30. PMID 23799460 DOI: 10.1097/Wnr.0B013E3283637845  0.243
2014 Callaway DA, Perkins DO, Woods SW, Liu L, Addington J. Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis. Schizophrenia Research. 159: 263-6. PMID 25311779 DOI: 10.1016/J.Schres.2014.09.031  0.242
2006 Cadenhead K, Addington J, Cannon T, Cornblatt B, Heinssen R, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S. WC8D THE DEVELOPMENT OF THE NAPLS DATASET AND BASELINE SAMPLE CHARACTERISTICS Schizophrenia Research. 86: S18. DOI: 10.1016/S0920-9964(06)70053-6  0.24
2013 Magaud E, Marshall C, Mancuso E, Addington J. Use of the Self-Esteem Rating Scale--Short Form in a first episode of psychosis sample. Schizophrenia Research. 143: 399-400. PMID 23265776 DOI: 10.1016/J.Schres.2012.11.022  0.24
2020 Mittal VA, Addington JM. Embracing heterogeneity creates new opportunities for understanding and treating those at clinical-high risk for psychosis. Schizophrenia Research. PMID 33288356 DOI: 10.1016/j.schres.2020.11.015  0.239
2021 Addington J, Liu L, Santesteban-Echarri O, Brummitt K, Braun A, Cadenhead KS, Cornblatt BA, Holden JL, Granholm E. Cognitive behavioural social skills training: Methods of a randomized controlled trial for youth at risk of psychosis. Early Intervention in Psychiatry. PMID 33398922 DOI: 10.1111/eip.13102  0.239
2006 Woods S, Addington J, Cadenhead K, Cannon T, Cornblatt B, Perkins D, Seidman L, Walker E, Tsuang M, McGlashan T, Heinssen R. WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS Schizophrenia Research. 86: S17. DOI: 10.1016/S0920-9964(06)70050-0  0.238
2021 Moore D, Castagnini E, Mifsud N, Geros H, Sizer H, Addington J, van der Gaag M, Nelson B, McGorry P, O'Donoghue B. The associations between migrant status and ethnicity and the identification of individuals at ultra-high risk for psychosis and transition to psychosis: a systematic review. Social Psychiatry and Psychiatric Epidemiology. PMID 33641006 DOI: 10.1007/s00127-021-02047-3  0.238
2023 Argote M, Sescousse G, Brunelin J, Baudin G, Schaub MP, Rabin R, Schnell T, Ringen PA, Andreassen OA, Addington JM, Brambilla P, Delvecchio G, Bechdolf A, Wobrock T, Schneider-Axmann T, et al. Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals. Eclinicalmedicine. 64: 102199. PMID 37731936 DOI: 10.1016/j.eclinm.2023.102199  0.238
2017 Zheutlin A, Jeffries C, Perkins D, Chung Y, Chekroud A, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Seidman LJ, Walker E, Woods S, Tsuang M, et al. SU96. The Role of MicroRNA Expression in Cortical Development During Conversion to Psychosis Schizophrenia Bulletin. 43: S196-S196. DOI: 10.1093/Schbul/Sbx024.092  0.235
2014 Deighton S, Addington J. Exercise practices of young people at their first episode of psychosis. Schizophrenia Research. 152: 311-2. PMID 24275584 DOI: 10.1016/J.Schres.2013.10.045  0.231
2023 Addington J, Chao A, Braun A, Miller M, Farris MS. Patient-Reported Outcome Measures in Clinical High Risk for Psychosis: A Systematic Review. Schizophrenia Bulletin Open. 4: sgad006. PMID 37025755 DOI: 10.1093/schizbullopen/sgad006  0.23
2006 Addington J, Saeedi H, Addington D. Weight gain in first-episode psychosis over three years. Schizophrenia Research. 86: 335-6. PMID 16887336 DOI: 10.1016/J.Schres.2006.06.035  0.229
1985 Fry P, Addington J. Perceptions of parent and child adjustment in divorced families Clinical Psychology Review. 5: 141-157. DOI: 10.1016/0272-7358(85)90019-4  0.228
2019 Kelsven S, Addington JM, Bearden CE, Cannon TD, Cornblatt B, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Walker EF, Woods SW, Cadenhead KS. T13. THE ASSOCIATION BETWEEN CHILDHOOD TRAUMA AND INFLAMMATION IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 45: S207-S208. DOI: 10.1093/Schbul/Sbz019.293  0.225
2021 Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, ... ... Addington J, et al. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Molecular Psychiatry. PMID 34024906 DOI: 10.1038/s41380-021-01128-8  0.225
2017 Barbato M, Buchy L, Bray S, MacMaster F, Deighton S, Addington J. Testing the feasibility of a computerized facial affect recognition training in early psychosis. Schizophrenia Research. PMID 28285735 DOI: 10.1016/J.Schres.2017.03.011  0.225
2021 Olde Loohuis LM, Mennigen E, Ori APS, Perkins D, Robinson E, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Keshavan MS, Stone WS, Tsuang MT, Walker EF, et al. Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Translational Psychiatry. 11: 80. PMID 33510130 DOI: 10.1038/s41398-021-01203-2  0.223
1992 Addington DE, Addington JM. Attempted suicide and depression in schizophrenia. Acta Psychiatrica Scandinavica. 85: 288-91. PMID 1595363 DOI: 10.1111/j.1600-0447.1992.tb01471.x  0.222
2017 Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. Exploration of clinical high-risk dropouts. Schizophrenia Research. PMID 28964651 DOI: 10.1016/J.Schres.2017.09.018  0.222
1990 Addington D, Addington J. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 35: 430-3. PMID 2372754 DOI: 10.1177/070674379003500512  0.221
2022 Duncan E, Roach BJ, Massa N, Hamilton HK, Bachman PM, Belger A, Carrion RE, Johannesen JK, Light GA, Niznikiewicz MA, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort. Schizophrenia Research. 248: 89-97. PMID 35994912 DOI: 10.1016/j.schres.2022.07.019  0.221
2002 Addington J, Addington D. Cognitive functioning in first-episode schizophrenia. Journal of Psychiatry & Neuroscience : Jpn. 27: 188-92. PMID 12066448  0.22
2021 Jacob MS, Roach BJ, Hamilton HK, Carrión RE, Belger A, Duncan E, Johannesen J, Keshavan M, Loo S, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study. Schizophrenia Research. 230: 26-37. PMID 33667856 DOI: 10.1016/j.schres.2021.01.028  0.22
1996 Addington J, Addington D. Cognitive and social functioning in schizophrenia outpatients who abuse substances Schizophrenia Research. 18: 224. DOI: 10.1016/0920-9964(96)85688-X  0.218
2024 Byrne JF, Healy C, Föcking M, Susai SR, Mongan D, Wynne K, Kodosaki E, Heurich M, de Haan L, Hickie IB, Smesny S, Thompson A, Markulev C, Young AR, Schäfer MR, ... ... Addington J, et al. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study. Schizophrenia Bulletin. PMID 38243809 DOI: 10.1093/schbul/sbad184  0.217
2008 Menon M, Anderson A, Schmitz T, Korostil M, Addington J, Kapur S. EXPLORING THE NEURAL CORRELATES OF DELUSIONS OF REFERENCE: AN fMRI STUDY Schizophrenia Research. 102: 90. DOI: 10.1016/S0920-9964(08)70273-1  0.216
2012 Piskulic D, Barbato M, Addington J. Poster #167 EFFECTS OF COGNITIVE REMEDIATION ON COGNITION IN YOUNG PEOPLE AT CLINICAL HIGH RISK OF PSYCHOSIS Schizophrenia Research. 136: S245-S246. DOI: 10.1016/S0920-9964(12)70739-9  0.215
2007 Pierson K, Addington D, Addington J, Patten S. Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 51: 715-8. PMID 17121171 DOI: 10.1177/070674370605101109  0.215
1996 Addington D, Addington J. The relationship between negative symptoms and depression in schizophrenia European Neuropsychopharmacology. 6: 62-63. DOI: 10.1016/0924-977X(96)87590-0  0.214
2021 Foss-Feig JH, Guillory SB, Roach BJ, Velthorst E, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington JM, Cadenhead KS, Cannon TD, et al. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study. Frontiers in Psychiatry. 12: 591127. PMID 33633603 DOI: 10.3389/fpsyt.2021.591127  0.213
2022 Oliver D, Arribas M, Radua J, Salazar de Pablo G, De Micheli A, Spada G, Mensi MM, Kotlicka-Antczak M, Borgatti R, Solmi M, Shin JI, Woods SW, Addington J, McGuire P, Fusar-Poli P. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis. Molecular Psychiatry. PMID 35665763 DOI: 10.1038/s41380-022-01611-w  0.212
2023 Addington J, Liu L, Braun A, Brummitt K, Cadenhead KS, Cornblatt BA, Holden JL, Granholm E. Cognitive-Behavioral Social Skills Training: Outcome of a Randomized Controlled Trial for Youth at Risk of Psychosis. Schizophrenia Bulletin Open. 4: sgad020. PMID 37601286 DOI: 10.1093/schizbullopen/sgad020  0.21
2020 Carrión RE, Auther AM, McLaughlin D, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman L, Stone W, Tsuang M, Walker EF, et al. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome. Schizophrenia Research. PMID 33131983 DOI: 10.1016/j.schres.2020.09.006  0.209
2023 Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Lympus CA, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Zhao Y, Cannon TD. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. Jama Psychiatry. PMID 37531131 DOI: 10.1001/jamapsychiatry.2023.2378  0.208
2006 Addington J, Zipursky R, Epstein I. WC2C ADAPT (ACCESS, DETECTION AND PSYCHOLOGICAL TREATMENTS) Schizophrenia Research. 86: S6. DOI: 10.1016/S0920-9964(06)70020-2  0.207
2002 van Mastrigt S, Addington J. Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. Journal of Psychiatry & Neuroscience : Jpn. 27: 92-101. PMID 11944510  0.205
2024 Williams TF, Williams AL, Cowan HR, Walker EF, Cannon TD, Bearden CE, Keshavan M, Cornblatt BA, Addington J, Woods SW, Perkins DO, Mathalon DH, Cadenhead KS, Stone WS, Mittal VA. The hierarchical taxonomy of psychopathology in clinical high risk for psychosis: Validation and extension. Journal of Psychopathology and Clinical Science. PMID 38546628 DOI: 10.1037/abn0000893  0.205
2012 Falukozi E, Addington J. Impact of Trauma on Attenuated Psychotic Symptoms. Psychosis. 4: 203-212. PMID 23155365 DOI: 10.1080/17522439.2011.62686712  0.204
2022 O'Brien Cannon AC, Caporino NE, O'Brien MP, Miklowitz DJ, Addington JM, Cannon TD. Family communication and the efficacy of family focused therapy in individuals at clinical high risk for psychosis with comorbid anxiety. Early Intervention in Psychiatry. PMID 35719024 DOI: 10.1111/eip.13326  0.202
2024 Miller M, Braun A, Cadenhead KS, Cornblatt BA, Granholm E, Addington J. Self-perceptions and depression in youth at risk of psychosis. Schizophrenia Research. 264: 231-232. PMID 38183960 DOI: 10.1016/j.schres.2023.12.031  0.2
1993 Addington D, Addington JM, Ens I. Mentally retarded patients on general hospital psychiatric units. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 38: 134-6. PMID 8080465 DOI: 10.1177/070674379303800212  0.2
2022 Robinson DG, Schooler NR, Marcy P, Gibbons RD, Hendricks Brown C, John M, Mueser KT, Penn DL, Rosenheck RA, Addington J, Brunette MF, Correll CU, Estroff SE, Mayer-Kalos PS, Gottlieb JD, et al. Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial. Schizophrenia Bulletin. PMID 35689478 DOI: 10.1093/schbul/sbac053  0.198
2003 Pencer A, Addington J. Models of substance use in adolescents experiencing a first episode of psychosis Schizophrenia Research. 60: 24. DOI: 10.1016/S0920-9964(03)80070-1  0.197
2021 Metzak PD, Farris MS, Placsko T, Braun A, Bonneville D, Brummitt K, Chu M, Addington J. Social functioning and brain imaging in individuals at clinical high-risk for psychosis: A systematic review. Schizophrenia Research. 233: 3-12. PMID 34126554 DOI: 10.1016/j.schres.2021.04.013  0.194
2020 Addington J, Farris MS, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Stone WS, Keshevan M, et al. Depression: An actionable outcome for those at clinical high-risk. Schizophrenia Research. PMID 33129638 DOI: 10.1016/j.schres.2020.10.001  0.193
2020 Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. Journal of Abnormal Psychology. 129: 599-611. PMID 32757603 DOI: 10.1037/abn0000513  0.193
1996 Addington J, Addington D. Cognitive functioning in schizophrenia: A trial of risperidone versus haloperidol European Neuropsychopharmacology. 6: 200. DOI: 10.1016/0924-977X(96)88241-1  0.192
2023 Ku BS, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Compton MT, Cornblatt BA, Druss BG, Gülöksüz S, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Carrión RE. Associations Between Childhood Area-Level Social Fragmentation, Maladaptation to School, and Social Functioning Among Healthy Youth and Those at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 37358832 DOI: 10.1093/schbul/sbad093  0.192
2020 Santesteban-Echarri O, Goreis A, Kafka JX, Scharinger C, Addington J, Felnhofer A, Mossaheb N, Plener PL, Kothgassner OD. T104. Psychotic-Like Experiences And Problematic Gaming Behavior In Online Game Forums Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa029.664  0.191
2021 Aberizk K, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Cannon TD, Walker EF. Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High-Risk for Psychosis and Healthy Youths. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 33930604 DOI: 10.1016/j.bpsc.2021.04.011  0.191
2022 Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, Goodyear BG, Bearden CE, Cadenhead KS, Mirzakhanian H, Tsuang MT, Cornblatt BA, Carrión RE, Keshavan M, Stone WS, et al. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk. Molecular Psychiatry. PMID 36434057 DOI: 10.1038/s41380-022-01870-7  0.19
2020 Devoe DJ, Farris MS, Townes P, Addington J. Interventions and Transition in Youth at Risk of Psychosis: A Systematic Review and Meta-Analyses. The Journal of Clinical Psychiatry. 81. PMID 32433834 DOI: 10.4088/JCP.17r12053  0.186
2009 Addington J, Lambert T, Burnett P. Complete and incomplete recovery from first-episode psychosis The Recognition and Management of Early Psychosis: a Preventive Approach, Second Edition. 201-222. DOI: 10.1017/CBO9780511576287.013  0.185
2011 Piskulic D, Addington J. Social cognition and negative symptoms in psychosis. Psychiatry Research. 188: 283-5. PMID 21571376 DOI: 10.1016/j.psychres.2011.04.028  0.185
2008 Compton MT, Goulding SM, Ramsay CE, Addington J, Corcoran C, Walker EF. EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA. Clinical Neuropsychiatry. 5: 263-272. PMID 26617643  0.185
2014 Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort Schizophrenia Research: Cognition. DOI: 10.1016/j.scog.2015.04.004  0.183
2023 Aberizk K, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF, Ku BS. Relations of Lifetime Perceived Stress and Basal Cortisol with Hippocampal Volume among Healthy Adolescents and those at Clinical High-Risk for Psychosis: A Structural Equation Modeling Approach. Biological Psychiatry. PMID 38092185 DOI: 10.1016/j.biopsych.2023.11.027  0.183
1997 Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study Schizophrenia Research. 24: 95. DOI: 10.1016/S0920-9964(97)82256-6  0.183
2024 Ho NCW, Bethlehem RA, Seidlitz J, Nogovitsyn N, Metzak P, Ballester PL, Hassel S, Rotzinger S, Poppenk J, Lam RW, Taylor VH, Milev R, Bullmore ET, Alexander-Bloch AF, Frey BN, ... ... Addington J, et al. Atypical brain aging and its association with working memory performance in major depressive disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 38679324 DOI: 10.1016/j.bpsc.2024.04.008  0.183
2000 Addington J, Addington D. Neurocognition in first episode schizophrenia: A 2 year follow-up Schizophrenia Research. 41: 271-272. DOI: 10.1016/S0920-9964(00)90984-8  0.182
1998 Addington J, Addington D. Neurocognitive functioning in first episode schizophrenia Schizophrenia Research. 29: 50-51. DOI: 10.1016/S0920-9964(97)88418-6  0.182
2010 Addington J, Piskulic D, Marshall C. Psychosocial Treatments for Schizophrenia Current Directions in Psychological Science. 19: 260-263. DOI: 10.1177/0963721410377743  0.18
2018 Cao H, McEwen S, Chung Y, Bearden C, Addington J, Goodyear B, Cadenhead K, Cornblatt B, Olvet D, Mathalon D, McGlashan T, Perkins D, Belger A, Seidman LJ, Tsuang M, et al. O3.2. BRAIN HYPERACTIVATION DURING MEMORY RETRIEVAL PRECEDES AND PREDICTS CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT CLINICAL HIGH RISK Schizophrenia Bulletin. 44: S79-S79. DOI: 10.1093/schbul/sby015.200  0.179
Hide low-probability matches.